Tumor suppressive protein phosphatases in human cancer: Emerging targets for therapeutic intervention and tumor stratification

Abbotts, 2014, Targeting human apurinic/apyrimidinic endonuclease 1 (APE1) in phosphatase and tensin homolog (PTEN) deficient melanoma cells for personalized therapy, Oncotarget, 5, 3273, 10.18632/oncotarget.1926 Abdelsaid, 2012, S-glutathionylation of LMW-PTP regulates VEGF-mediated FAK activation and endothelial cell migration, J. Cell Sci., 125, 4751, 10.1242/jcs.103481 Acun, 2015, PTPRD is homozygously deleted and epigenetically downregulated in human hepatocellular carcinomas, OMICS, 19, 220, 10.1089/omi.2015.0010 Adams, 2005, Positive regulation of Raf1-MEK1/2-ERK1/2 signaling by protein serine/threonine phosphatase 2A holoenzymes, J. Biol. Chem., 280, 42644, 10.1074/jbc.M502464200 Agarwal, 2013, Tumor derived mutations of protein tyrosine phosphatase receptor type k affect its function and alter sensitivity to chemotherapeutics in glioma, PLoS One, 8, e62852, 10.1371/journal.pone.0062852 Agarwal, 2014, Antagonism of SET using OP449 enhances the efficacy of tyrosine kinase inhibitors and overcomes drug resistance in myeloid leukemia, Clin. Cancer Res., 20, 2092, 10.1158/1078-0432.CCR-13-2575 Aguiar, 1999, PTPROt: an alternatively spliced and developmentally regulated B-lymphoid phosphatase that promotes G0/G1 arrest, Blood, 94, 2403, 10.1182/blood.V94.7.2403.419k39_2403_2413 Aguirre-Ghiso, 2003, ERK(MAPK) activity as a determinant of tumor growth and dormancy; regulation by p38(SAPK), Cancer Res., 63, 1684 Al-Shehhi, 2013, Abnormalities of the der(12)t(12;21) in ETV6-RUNX1 acute lymphoblastic leukemia, Genes Chromosomes Cancer, 52, 202, 10.1002/gcc.22021 Alho, 2013, The role of low-molecular-weight protein tyrosine phosphatase (LMW-PTP ACP1) in oncogenesis, Tumour Biol., 34, 1979, 10.1007/s13277-013-0784-1 Alho, 2013, Characterization of low molecular weight protein tyrosine phosphatase isoforms in human breast cancer epithelial cell lines, Anticancer Res., 33, 1983 Alonso, 2016, The extended human PTPome: a growing tyrosine phosphatase family, FEBS J., 283, 1404, 10.1111/febs.13600 Alonso, 2002, Inhibition of T cell antigen receptor signaling by VHR-related MKPX (VHX), a new dual specificity phosphatase related to VH1 related (VHR), J. Biol. Chem., 277, 5524, 10.1074/jbc.M107653200 Alonso, 2003, Tyrosine phosphorylation of VHR phosphatase by ZAP-70, Nat. Immunol., 4, 44, 10.1038/ni856 Alonso, 2004, Protein tyrosine phosphatases in the human genome, Cell, 117, 699, 10.1016/j.cell.2004.05.018 Althubiti, 2014, Characterization of novel markers of senescence and their prognostic potential in cancer, Cell Death Dis., 5, e1528, 10.1038/cddis.2014.489 Amand, 2014, DUSP3/VHR is a pro-angiogenic atypical dual-specificity phosphatase, Mol. Cancer, 13, 108, 10.1186/1476-4598-13-108 Amin, 2007, Decreased expression level of SH2 domain-containing protein tyrosine phosphatase-1 (Shp1) is associated with progression of chronic myeloid leukaemia, J. Pathol., 212, 402, 10.1002/path.2178 Araujo, 2016, Transmembrane prostatic acid phosphatase (TMPAP) delays cells in G1 phase of the cell cycle, Prostate, 76, 151, 10.1002/pros.23105 Ardini, 2000, Expression of protein tyrosine phosphatase alpha (RPTPalpha) in human breast cancer correlates with low tumor grade, and inhibits tumor cell growth in vitro and in vivo, Oncogene, 19, 4979, 10.1038/sj.onc.1203869 Armes, 2004, Candidate tumor-suppressor genes on chromosome arm 8p in early-onset and high-grade breast cancers, Oncogene, 23, 5697, 10.1038/sj.onc.1207740 Arnold, 2006, Protein phosphatase 2A regulatory subunit B56alpha associates with c-myc and negatively regulates c-myc accumulation, Mol. Cell. Biol., 26, 2832, 10.1128/MCB.26.7.2832-2844.2006 Arnoldussen, 2008, The mitogen-activated protein kinase phosphatase vaccinia H1-related protein inhibits apoptosis in prostate cancer cells and is overexpressed in prostate cancer, Cancer Res., 68, 9255, 10.1158/0008-5472.CAN-08-1224 Arora, 2011, Protein-tyrosine phosphatase DEP-1 controls receptor tyrosine kinase FLT3 signaling, J. Biol. Chem., 286, 10918, 10.1074/jbc.M110.205021 Arriazu, 2016, Protein phosphatase 2A as a therapeutic target in acute myeloid leukemia, Front. Oncol., 6, 78, 10.3389/fonc.2016.00078 Arroyo-Berdugo, 2014, Involvement of ANXA5 and ILKAP in susceptibility to malignant melanoma, PLoS One, 9, e95522, 10.1371/journal.pone.0095522 Arruga, 2017, Mutations in NOTCH1 PEST domain orchestrate CCL19-driven homing of chronic lymphocytic leukemia cells by modulating the tumor suppressor gene DUSP22, Leukemia, 31, 1882, 10.1038/leu.2016.383 Asbagh, 2014, The tyrosine phosphatase PTPRO sensitizes colon cancer cells to anti-EGFR therapy through activation of SRC-mediated EGFR signaling, Oncotarget, 5, 10070, 10.18632/oncotarget.2458 Assem, 2012, Enhancing diagnosis, prognosis, and therapeutic outcome prediction of gliomas using genomics, OMICS, 16, 113, 10.1089/omi.2011.0031 Astolfi, 2010, A molecular portrait of gastrointestinal stromal tumors: an integrative analysis of gene expression profiling and high-resolution genomic copy number, Lab. Invest., 90, 1285, 10.1038/labinvest.2010.110 Aya-Bonilla, 2013, High-resolution loss of heterozygosity screening implicates PTPRJ as a potential tumor suppressor gene that affects susceptibility to Non-Hodgkin's lymphoma, Genes Chromosomes Cancer, 52, 467, 10.1002/gcc.22044 Baghbani, 2017, Suppression of protein tyrosine phosphatase PTPN22 gene induces apoptosis in T-cell leukemia cell line (Jurkat) through the AKT and ERK pathways, Biomed. Pharmacother., 86, 41, 10.1016/j.biopha.2016.11.124 Baker, 2001, Protein tyrosine phosphatase CD148-mediated inhibition of T-cell receptor signal transduction is associated with reduced LAT and phospholipase Cgamma1 phosphorylation, Mol. Cell. Biol., 21, 2393, 10.1128/MCB.21.7.2393-2403.2001 Balavenkatraman, 2006, DEP-1 protein tyrosine phosphatase inhibits proliferation and migration of colon carcinoma cells and is upregulated by protective nutrients, Oncogene, 25, 6319, 10.1038/sj.onc.1209647 Bang, 1998, Increased MAPK activity and MKP-1 overexpression in human gastric adenocarcinoma, Biochem. Biophys. Res. Commun., 250, 43, 10.1006/bbrc.1998.9256 Barghorn, 2001, Putative tumor suppressor loci at 6q22 and 6q23-q24 are involved in the malignant progression of sporadic endocrine pancreatic tumors, Am. J. Pathol., 158, 1903, 10.1016/S0002-9440(10)64658-5 Barron, 2015, CDKN3 mRNA as a biomarker for survival and therapeutic target in cervical cancer, PLoS One, 10, e0137397, 10.1371/journal.pone.0137397 Bassermann, 2008, The Cdc14B-Cdh1-Plk1 axis controls the G2 DNA-damage-response checkpoint, Cell, 134, 256, 10.1016/j.cell.2008.05.043 Basu, 2011, PP2A in the regulation of cell motility and invasion, Curr. Protein Pept. Sci., 12, 3, 10.2174/138920311795659443 Batut, 2008, Two highly related regulatory subunits of PP2A exert opposite effects on TGF-beta/Activin/Nodal signalling, Development, 135, 2927, 10.1242/dev.020842 Beaulieu, 2005, An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior, Cell, 122, 261, 10.1016/j.cell.2005.05.012 Beca, 2015, Altered PPP2R2A and Cyclin D1 expression defines a subgroup of aggressive luminal-like breast cancer, BMC Cancer, 15, 285, 10.1186/s12885-015-1266-1 Becka, 2010, Characterization of the adhesive properties of the type IIb subfamily receptor protein tyrosine phosphatases, Cell Commun. Adhes., 17, 34, 10.3109/15419061.2010.487957 Behjati, 2014, Recurrent PTPRB and PLCG1 mutations in angiosarcoma, Nat. Genet., 46, 376, 10.1038/ng.2921 Belle, 2015, The tyrosine phosphatase PTPN14 (Pez) inhibits metastasis by altering protein trafficking, Sci. Signal., 8, ra18, 10.1126/scisignal.2005547 Benitez, 2017, PTEN regulates glioblastoma oncogenesis through chromatin-associated complexes of DAXX and histone H3.3, Nat. Commun., 8, 15223, 10.1038/ncomms15223 Beothe, 2015, Homozygous losses detected by array comparative genomic hybridization in multiplex urothelial carcinomas of the bladder, Cancer Genet., 208, 434, 10.1016/j.cancergen.2015.05.029 Bernard-Pierrot, 2008, Characterization of the recurrent 8p 11-12 amplicon identifies PPAPDC1B, a phosphatase protein, as a new therapeutic target in breast cancer, Cancer Res., 68, 7165, 10.1158/0008-5472.CAN-08-1360 Berset, 2015, The C. elegans homolog of the mammalian tumor suppressor Dep-1/Scc1 inhibits EGFR signaling to regulate binary cell fate decisions, Genes Dev., 19, 1328, 10.1101/gad.333505 Besco, 2006, Intracellular substrates of brain-enriched receptor protein tyrosine phosphatase rho (RPTPrho/PTPRT), Brain Res., 1116, 50, 10.1016/j.brainres.2006.07.122 Bi, 2016, miR-1301 promotes prostate cancer proliferation through directly targeting PPP2R2C, Biomed. Pharmacother., 81, 25, 10.1016/j.biopha.2016.03.043 Bian, 2014, Synthetic genetic array screen identifies PP2A as a therapeutic target in Mad2-overexpressing tumors, Proc. Natl. Acad. Sci. U. S. A., 111, 1628, 10.1073/pnas.1315588111 Bianchini, 2007, cDNA microarray study to identify expression changes relevant for apoptosis in K562 cells co-treated with amifostine and imatinib, Cancer Chemother. Pharmacol., 59, 349, 10.1007/s00280-006-0276-8 Bloethner, 2005, Effect of common B-RAF and N-RAS mutations on global gene expression in melanoma cell lines, Carcinogenesis, 26, 1224, 10.1093/carcin/bgi066 Bluemn, 2013, PPP2R2C loss promotes castration-resistance and is associated with increased prostate cancer-specific mortality, Mol. Cancer Res., 11, 568, 10.1158/1541-7786.MCR-12-0710 Bompard, 2002, Protein-tyrosine phosphatase PTPL1/FAP-1 triggers apoptosis in human breast cancer cells, J. Biol. Chem., 277, 47861, 10.1074/jbc.M208950200 Bonilla, 2016, Genomic analysis identifies new drivers and progression pathways in skin basal cell carcinoma, Nat. Genet., 48, 398, 10.1038/ng.3525 Boulding, 2016, Differential roles for DUSP family members in epithelial-to-mesenchymal transition and cancer stem cell regulation in Breast cancer, PLoS One, 11, e0148065, 10.1371/journal.pone.0148065 Bourgonje, 2016, Comprehensive protein tyrosine phosphatase mRNA profiling identifies new regulators in the progression of glioma, Acta Neuropathol. Commun., 4, 96, 10.1186/s40478-016-0372-x Boutros, 2007, CDC25 phosphatases in cancer cells: key players? Good targets?, Nat. Rev. Cancer, 7, 495, 10.1038/nrc2169 Boutros, 2008, Mitogen-activated protein (MAP) kinase/MAP kinase phosphatase regulation: roles in cell growth, death, and cancer, Pharmacol. Rev., 60, 261, 10.1124/pr.107.00106 Braggio, 2010, Methylation status of nine tumor suppressor genes in multiple myeloma, Int. J. Hematol., 91, 87, 10.1007/s12185-009-0459-2 Britson, 2009, Deregulation of DUSP activity in EGFR-mutant lung cancer cell lines contributes to sustained ERK1/2 signaling, Biochem. Biophys. Res. Commun., 390, 849, 10.1016/j.bbrc.2009.10.061 Broderick, 2017, Validation of recently proposed colorectal cancer susceptibility gene variants in an analysis of families and patients-a systematic review, Gastroenterology, 152, 75, 10.1053/j.gastro.2016.09.041 Brognard, 2007, PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of Akt signaling by regulating distinct Akt isoforms, Mol. Cell, 25, 917, 10.1016/j.molcel.2007.02.017 Bruecher-Encke, 2001, Role of the tyrosine phosphatase SHP-1 in K562 cell differentiation, Leukemia, 15, 1424, 10.1038/sj.leu.2402214 Bujko, 2015, Expression changes of cell–cell adhesion-related genes in colorectal tumors, Oncol Lett., 9, 2463, 10.3892/ol.2015.3107 Burgoyne, 2009, PTPmu suppresses glioma cell migration and dispersal, Neuro Oncol., 11, 767, 10.1215/15228517-2009-019 Cai, 2013, miR-205 targets PTEN and PHLPP2 to augment AKT signaling and drive malignant phenotypes in non-small cell lung cancer, Cancer Res., 73, 5402, 10.1158/0008-5472.CAN-13-0297 Cai, 2015, Down-regulation of dual-specificity phosphatase 5 predicts poor prognosis of patients with prostate cancer, Int. J. Clin. Exp. Med., 8, 4186 Calin, 2000, Low frequency of alterations of the alpha (PPP2R1A) and beta (PPP2R1B) isoforms of the subunit A of the serine-threonine phosphatase 2A in human neoplasms, Oncogene, 19, 1191, 10.1038/sj.onc.1203389 Calvisi, 2008, Dual-specificity phosphatase 1 ubiquitination in extracellular signal-regulated kinase-mediated control of growth in human hepatocellular carcinoma, Cancer Res., 68, 4192, 10.1158/0008-5472.CAN-07-6157 Cao, 2012, Tyrosine-protein phosphatase nonreceptor type 12 is a novel prognostic biomarker for esophageal squamous cell carcinoma, Ann. Thorac. Surg., 93, 1674, 10.1016/j.athoracsur.2011.12.056 Cao, 2015, Tyrosine-protein phosphatase non-receptor type 12 expression is a good prognostic factor in resectable non-small cell lung cancer, Oncotarget, 6, 11704, 10.18632/oncotarget.3588 Cardinale, 2014, PTPN3 mutations and HBV may exert synergistic effects in the origin of the intrahepatic cholangiocarcinoma, Gastroenterology, 147, 719, 10.1053/j.gastro.2014.05.046 Carpenter, 1978, Epidermal growth factor stimulates phosphorylation in membrane preparations in vitro, Nature, 276, 409, 10.1038/276409a0 Catlett-Falcone, 1999, Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells, Immunity, 10, 105, 10.1016/S1074-7613(00)80011-4 Cengiz, 2007, Fine deletion mapping of chromosome 2q21-37 shows three preferentially deleted regions in oral cancer, Oral Oncol., 43, 241, 10.1016/j.oraloncology.2006.03.004 Challouf, 2012, Patterns of aberrant DNA hypermethylation in nasopharyngeal carcinoma in Tunisian patients, Clin. Chim. Acta, 413, 795, 10.1016/j.cca.2012.01.018 Chan, 2008, Loss of MKP3 mediated by oxidative stress enhances tumorigenicity and chemoresistance of ovarian cancer cells, Carcinogenesis, 29, 1742, 10.1093/carcin/bgn167 Chang, 2014, MicroRNA-331-3p promotes proliferation and metastasis of hepatocellular carcinoma by targeting PH domain and leucine-rich repeat protein phosphatase, Hepatology, 60, 1251, 10.1002/hep.27221 Chang, 2014, High methylation rate of LMX1A, NKX6-1, PAX1, PTPRR, SOX1, and ZNF582 genes in cervical adenocarcinoma, Int. J. Gynecol. Cancer, 24, 201, 10.1097/IGC.0000000000000054 Chao, 2015, Afatinib induces apoptosis in NSCLC without EGFR mutation through Elk-1-mediated suppression of CIP2A, Oncotarget, 6, 2164, 10.18632/oncotarget.2941 Chen, 2004, Identification of specific PP2A complexes involved in human cell transformation, Cancer Cell, 5, 127, 10.1016/S1535-6108(04)00026-1 Chen, 2005, Cancer-associated PP2A Aalpha subunits induce functional haploinsufficiency and tumorigenicity, Cancer Res., 65, 8183, 10.1158/0008-5472.CAN-05-1103 Chen, 2006, Protein tyrosine phosphatase receptor-type O truncated (PTPROt) regulates SYK phosphorylation, proximal B-cell-receptor signaling, and cellular proliferation, Blood, 108, 3428, 10.1182/blood-2006-03-013821 Chen, 2007, A five-gene signature and clinical outcome in non-small-cell lung cancer, N. Engl. J. Med., 356, 11, 10.1056/NEJMoa060096 Chen, 2014, A critical role of CDKN3 in Bcr-Abl-mediated tumorigenesis, PLoS One, 9, e111611, 10.1371/journal.pone.0111611 Chen, 2015, Low expression of PHLPP1 in sacral chordoma and its association with poor prognosis, Int. J. Clin. Exp. Pathol., 8, 14741 Chen, 2015, Receptor-type tyrosine-protein phosphatase kappa directly targets STAT3 activation for tumor suppression in nasal NK/T-cell lymphoma, Blood, 125, 1589, 10.1182/blood-2014-07-588970 Chen, 2015, The importance of Src signaling in sarcoma, Oncol. Lett., 10, 17, 10.3892/ol.2015.3184 Chen, 2016, Human phosphatase CDC14A is recruited to the cell leading edge to regulate cell migration and adhesion, Proc. Natl. Acad. Sci. U. S. A., 113, 990, 10.1073/pnas.1515605113 Chen, 2017, Human phosphatase CDC14A regulates actin organization through dephosphorylation of epithelial protein lost in neoplasm, Proc. Natl. Acad. Sci. U. S. A., 114, 5201, 10.1073/pnas.1619356114 Chen, 2017, Deficiency in VHR/DUSP3, a suppressor of focal adhesion kinase, reveals its role in regulating cell adhesion and migration, Oncogene, 10.1038/onc.2017.255 Cheng, 2000, Dephosphorylation of human cyclin-dependent kinases by protein phosphatase type 2C alpha and beta 2 isoforms, J. Biol. Chem., 275, 34744, 10.1074/jbc.M006210200 Cheng, 2011, Evaluation of PPP2R2A as a prostate cancer susceptibility gene: a comprehensive germline and somatic study, Cancer Genet., 204, 375, 10.1016/j.cancergen.2011.05.002 Chiarugi, 1995, PDGF receptor as a specific in vivo target for low M(r) phosphotyrosine protein phosphatase, FEBS Lett., 372, 49, 10.1016/0014-5793(95)00947-8 Chien, 2015, Activation of protein phosphatase 2A tumor suppressor as potential treatment of pancreatic cancer, Mol. Oncol., 9, 889, 10.1016/j.molonc.2015.01.002 Chiesa, 2011, The Cdc14B phosphatase displays oncogenic activity mediated by the Ras-Mek signaling pathway, Cell Cycle, 10, 1607, 10.4161/cc.10.10.15566 Chim, 2004, SOCS1 and SHP1 hypermethylation in multiple myeloma: implications for epigenetic activation of the Jak/STAT pathway, Blood, 103, 4630, 10.1182/blood-2003-06-2007 Chim, 2004, Epigenetic dysregulation of the Jak/STAT pathway by frequent aberrant methylation of SHP1 but not SOCS1 in acute leukaemias, Ann. Hematol., 83, 527, 10.1007/s00277-004-0843-1 Chitale, 2009, An integrated genomic analysis of lung cancer reveals loss of DUSP4 in EGFR-mutant tumors, Oncogene, 28, 2773, 10.1038/onc.2009.135 Chung, 2013, Meta-analysis identifies four new loci associated with testicular germ cell tumor, Nat. Genet., 45, 680, 10.1038/ng.2634 Chung, 2016, Safety, tolerability, and preliminary activity of LB-100, an inhibitor of protein phosphatase 2A, in patients with relapsed solid tumors: an open-label, dose escalation, first-in-human, phase I trial, Clin. Cancer Res., 23, 3277, 10.1158/1078-0432.CCR-16-2299 Ciccone, 2015, From the biology of PP2A to the PADs for therapy of hematologic malignancies, Front. Oncol., 5, 21, 10.3389/fonc.2015.00021 Colella, 2001, Reduced expression of the Aalpha subunit of protein phosphatase 2A in human gliomas in the absence of mutations in the Aalpha and Abeta subunit genes, Int. J. Cancer, 93, 798, 10.1002/ijc.1423 Collett, 1978, Protein kinase activity associated with the avian sarcoma virus src gene product, Proc. Natl. Acad. Sci. U. S. A., 75, 2021, 10.1073/pnas.75.4.2021 Creyghton, 2006, PR130 is a modulator of the Wnt-signaling cascade that counters repression of the antagonist Naked cuticle, Proc. Natl. Acad. Sci. U. S. A., 103, 5397, 10.1073/pnas.0507237103 Cristóbal, 2011, PP2A impaired activity is a common event in acute myeloid leukemia and its activation by forskolin has a potent anti-leukemic effect, Leukemia, 25, 606, 10.1038/leu.2010.294 Cristóbal, 2013, Downregulation of PPP2R5E is a common event in acute myeloid leukemia that affects the oncogenic potential of leukemic cells, Haematologica, 98, e103, 10.3324/haematol.2013.084731 Cristóbal, 2016, Potential anti-tumor effects of FTY720 associated with PP2A activation: a brief review, Curr. Med. Res. Opin., 32, 1137, 10.1185/03007995.2016.1162774 Cristóbal, 2017, Downregulation of microRNA-199b predicts unfavorable prognosis and emerges as a novel therapeutic target which contributes to PP2A inhibition in metastatic colorectal cancer, Oncotarget, 8, 40169, 10.18632/oncotarget.11174 Croonquist, 2003, Gene profiling of a myeloma cell line reveals similarities and unique signatures among IL-6 response, N-ras-activating mutations, and coculture with bone marrow stromal cells, Blood, 102, 2581, 10.1182/blood-2003-04-1227 Csikesz, 2013, Primary cutaneous CD30-positive T-cell lymphoproliferative disorders with biallelic rearrangements of DUSP22, J. Invest. Dermatol., 133, 1680, 10.1038/jid.2013.22 Cui, 1996, TGFbeta1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice, Cell, 86, 531, 10.1016/S0092-8674(00)80127-0 Cui, 2006, Elevated expression of mitogen-activated protein kinase phosphatase 3 in breast tumors: a mechanism of tamoxifen resistance, Cancer Res., 66, 5950, 10.1158/0008-5472.CAN-05-3243 Cui, 2014, High levels of KAP1 expression are associated with aggressive clinical features in ovarian cancer, Int. J. Mol. Sci., 16, 363, 10.3390/ijms16010363 Cunningham, 2016, Therapeutic relevance of the protein phosphatase 2A in cancer, Oncotarget, 7, 61544, 10.18632/oncotarget.11399 Curtis, 2012, The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups, Nature, 486, 346, 10.1038/nature10983 Dai, 2011, PPM1A dephosphorylates RanBP3 to enable efficient nuclear export of Smad2 and Smad3, EMBO Rep., 12, 1175, 10.1038/embor.2011.174 Darnell, 2005, Validating Stat3 in cancer therapy, Nat. Med., 11, 595, 10.1038/nm0605-595 David, 1995, Differential regulation of the alpha/beta interferon-stimulated Jak/Stat pathway by the SH2 domain-containing tyrosine phosphatase SHPTP1, Mol. Cell. Biol., 15, 7050, 10.1128/MCB.15.12.7050 Deichmann, 2001, The protein phosphatase 2A subunit Bgamma gene is identified to be differentially expressed in malignant melanomas by subtractive suppression hybridization, Melanoma Res., 11, 577, 10.1097/00008390-200112000-00004 Deng, 2016, Methylation and expression of PTPN22 in esophageal squamous cell carcinoma, Oncotarget, 7, 64043, 10.18632/oncotarget.11581 Denkert, 2002, Expression of mitogen-activated protein kinase phosphatase-1 (MKP-1) in primary human ovarian carcinoma, Int. J. Cancer, 102, 507, 10.1002/ijc.10746 Derynck, 2001, TGF-beta signaling in tumor suppression and cancer progression, Nat. Genet., 29, 117, 10.1038/ng1001-117 d'Amore, 2012, Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01, J. Clin. Oncol., 30, 3093, 10.1200/JCO.2011.40.2719 de Voer, 2016, Identification of novel candidate genes for early-onset colorectal cancer susceptibility, PLoS Genet., 12, e1005880, 10.1371/journal.pgen.1005880 Di Conza, 2017, The mTOR and PP2A pathways regulate PHD2 phosphorylation to fine-tune HIF1α levels and colorectal cancer cell survival under hypoxia, Cell Rep., 18, 1699, 10.1016/j.celrep.2017.01.051 Di Conza, 2017, PHD2 targeting overcomes breast cancer cell death upon glucose starvation in a PP2A/B55α-mediated manner, Cell Rep., 18, 2836, 10.1016/j.celrep.2017.02.081 Dillon, 2014, Therapeutic targeting of cancers with loss of PTEN function, Curr. Drug Targets, 15, 65, 10.2174/1389450114666140106100909 Ding, 2017, MicroRNA-27a contributes to the malignant behavior of gastric cancer cells by directly targeting PH domain and leucine-rich repeat protein phosphatase 2, J. Exp. Clin. Cancer Res., 36, 45, 10.1186/s13046-017-0516-2 Dong, 2017, PTPRO represses ERBB2-driven breast oncogenesis by dephosphorylation and endosomal internalization of ERBB2, Oncogene, 36, 410, 10.1038/onc.2016.213 Dromard, 2007, The putative tumor suppressor gene PTPN13/PTPL1 induces apoptosis through insulin receptor substrate-1 dephosphorylation, Cancer Res., 67, 6806, 10.1158/0008-5472.CAN-07-0513 Du WW, 2013, MicroRNA miR-24 enhances tumor invasion and metastasis by targeting PTPN9 and PTPRF to promote EGF signaling, J. Cell Sci., 126, 1440, 10.1242/jcs.118299 Eckhart, 1979, An activity phosphorylating tyrosine in polyoma T antigen immunoprecipitates, Cell, 18, 925, 10.1016/0092-8674(79)90205-8 Eichhorn, 2007, A RNA interference screen identifies the protein phosphatase 2A subunit PR55gamma as a stress-sensitive inhibitor of c-SRC, PLoS Genet., 3, e218, 10.1371/journal.pgen.0030218 Eichhorn, 2009, Protein phosphatase 2A regulatory subunits and cancer, Biochim. Biophys. Acta, 1795, 1 ElShamy, 2004, Identification of BRCA1-IRIS, a BRCA1 locus product, Nat. Cell Biol., 6, 954, 10.1038/ncb1171 Elson, 2017, Stepping out of the shadows: oncogenic and tumor-promoting protein tyrosine phosphatases, Int. J. Biochem. Cell Biol. Escós, 2016, P38γ and p38δ mitogen activated protein kinases (MAPKs), new stars in the MAPK galaxy, Front. Cell Dev. Biol., 4, 31, 10.3389/fcell.2016.00031 Fan, 2013, Over expression of PPP2R2C inhibits human glioma cells growth through the suppression of mTOR pathway, FEBS Lett., 587, 3892, 10.1016/j.febslet.2013.09.029 Fan, 2014, Tyr phosphorylation of PDP1 toggles recruitment between ACAT1 and SIRT3 to regulate the pyruvate dehydrogenase complex, Mol. Cell, 53, 534, 10.1016/j.molcel.2013.12.026 Fan, 2014, SHP-1 is a target of regorafenib in colorectal cancer, Oncotarget, 5, 6243, 10.18632/oncotarget.2191 Fan, 2015, Overexpression of major CDKN3 transcripts is associated with poor survival in lung adenocarcinoma, Br. J. Cancer, 113, 1735, 10.1038/bjc.2015.378 Fan, 2016, Phosphatase PPM1A is a novel prognostic marker in pancreatic ductal adenocarcinoma, Hum. Pathol., 55, 151, 10.1016/j.humpath.2016.05.002 Feldman, 2011, Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing, Blood, 117, 915, 10.1182/blood-2010-08-303305 Feng, 2017, Genetic variants of PTPN2 are associated with lung cancer risk: a re-analysis of eight GWASs in the TRICL-ILCCO consortium, Sci. Rep., 7, 825, 10.1038/s41598-017-00850-0 Feurstein, 2014, Haploinsufficiency of ETV6 and CDKN1B in patients with acute myeloid leukemia and complex karyotype, BMC Genomics, 15, 784, 10.1186/1471-2164-15-784 Fiaschi, 2001, Low molecular weight protein-tyrosine phosphatase is involved in growth inhibition during cell differentiation, J. Biol. Chem., 276, 49156, 10.1074/jbc.M107538200 Forsterova, 2010, Advanced rai stage in patients with chronic lymphocytic leukaemia correlates with simultaneous hypermethylation of plural tumour suppressor genes, Folia Biol. (Praha), 56, 158 Forti, 2015, Combined experimental and bioinformatics analysis for the prediction and identification of VHR/DUSP3 nuclear targets related to DNA damage and repair, Integr. Biol. (Camb), 7, 73, 10.1039/C4IB00186A Fridberg, 2008, Immunohistochemical analyses of phosphatases in childhood B-cell lymphoma: lower expression of PTEN and HePTP and higher number of positive cells for nuclear SHP2 in B-cell lymphoma cases compared to controls, Pediatr. Hematol. Oncol., 25, 528, 10.1080/08880010802237054 Funato, 2011, Tyrosine phosphatase PTPRD suppresses colon cancer cell migration in coordination with CD44, Exp. Ther. Med., 2, 457, 10.3892/etm.2011.231 Furukawa, 2003, Potential tumor suppressive pathway involving DUSP6/MKP-3 in pancreatic cancer, Am. J. Pathol., 162, 1807, 10.1016/S0002-9440(10)64315-5 Furukawa, 2005, Distinct progression pathways involving the dysfunction of DUSP6/MKP-3 in pancreatic intraepithelial neoplasia and intraductal papillary-mucinous neoplasms of the pancreas, Mod. Pathol., 18, 1034, 10.1038/modpathol.3800383 Gaedcke, 2010, Mutated KRAS results in overexpression of DUSP4, a MAP-kinase phosphatase, and SMYD3, a histone methyltransferase, in rectal carcinomas, Genes Chromosomes Cancer, 49, 1024, 10.1002/gcc.20811 Galeano, 2013, ADAR2-editing activity inhibits glioblastoma growth through the modulation of the CDC14B/Skp2/p21/p27 axis, Oncogene, 32, 998, 10.1038/onc.2012.125 Gangula, 2013, WD repeat protein WDR48 in complex with deubiquitinase USP12 suppresses Akt-dependent cell survival signaling by stabilizing PH domain leucine-rich repeat protein phosphatase 1 (PHLPP1), J. Biol. Chem., 288, 34545, 10.1074/jbc.M113.503383 Gao, 2005, PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth, Mol. Cell, 18, 13, 10.1016/j.molcel.2005.03.008 Gao, 2008, The phosphatase PHLPP controls the cellular levels of protein kinase C, J. Biol. Chem., 283, 6300, 10.1074/jbc.M707319200 Gao, 2014, Activating mutations in PTPN3 promote cholangiocarcinoma cell proliferation and migration and are associated with tumor recurrence in patients, Gastroenterology, 146, 1397, 10.1053/j.gastro.2014.01.062 Geng, 2014, Loss of PPM1A expression enhances invasion and the epithelial-to-mesenchymal transition in bladder cancer by activating the TGF-β/Smad signaling pathway, Oncotarget, 5, 5700, 10.18632/oncotarget.2144 Giefing, 2011, High resolution ArrayCGH and expression profiling identifies PTPRD and PCDH17/PCH68 as tumor suppressor gene candidates in laryngeal squamous cell carcinoma, Genes Chromosomes Cancer, 50, 154, 10.1002/gcc.20840 Gilan, 2015, PR55α-containing protein phosphatase 2A complexes promote cancer cell migration and invasion through regulation of AP-1 transcriptional activity, Oncogene, 34, 1333, 10.1038/onc.2014.26 Givant-Horwitz, 2004, The PAC-1 dual specificity phosphatase predicts poor outcome in serous ovarian carcinoma, Gynecol. Oncol., 93, 517, 10.1016/j.ygyno.2004.03.009 Glondu-Lassis, 2010, PTPL1/PTPN13 regulates breast cancer cell aggressiveness through direct inactivation of Src kinase, Cancer Res., 70, 5116, 10.1158/0008-5472.CAN-09-4368 Griswold-Prenner, 1998, Physical and functional interactions between type I transforming growth factor beta receptors and Balpha, a WD-40 repeat subunit of phosphatase 2A, Mol. Cell. Biol., 18, 6595, 10.1128/MCB.18.11.6595 Grzechnik, 2016, PHLPPing through history: a decade in the life of PHLPP phosphatases, Biochem. Soc. Trans., 44, 1675, 10.1042/BST20160170 Gu, 2015, MicroRNA-145 inhibits human papillary cancer TPC1 cell proliferation by targeting DUSP6, Int. J. Clin. Exp. Med., 8, 8590 Gutierrez, 2014, Phenothiazines induce PP2A-mediated apoptosis in T cell acute lymphoblastic leukemia, J. Clin. Invest., 124, 644, 10.1172/JCI65093 Gutteridge, 2017, Targeted knockdown of polo-like kinase 1 alters metabolic regulation in melanoma, Cancer Lett., 394, 13, 10.1016/j.canlet.2017.02.013 Haag, 2016, The dual specificity phosphatase 2 gene is hypermethylated in human cancer and regulated by epigenetic mechanisms, BMC Cancer, 16, 49, 10.1186/s12885-016-2087-6 Hachana, 2009, Evidence for a role of the Simian Virus 40 in human breast carcinomas, Breast Cancer Res. Treat., 113, 43, 10.1007/s10549-008-9901-z Haesen, 2016, Recurrent PPP2R1A mutations in uterine cancer act through a dominant-negative mechanism to promote malignant cell growth, Cancer Res., 76, 5719, 10.1158/0008-5472.CAN-15-3342 Hahn, 2002, Rules for making human tumor cells, N. Engl. J. Med., 347, 1593, 10.1056/NEJMra021902 Hahn, 1999, Creation of human tumour cells with defined genetic elements, Nature, 400, 464, 10.1038/22780 Hahn, 2002, Enumeration of the simian virus 40 early region elements necessary for human cell transformation, Mol. Cell. Biol., 22, 2111, 10.1128/MCB.22.7.2111-2123.2002 Hahn, 2010, PP2A regulatory subunit PP2A-B' counteracts S6K phosphorylation, Cell Metab., 11, 438, 10.1016/j.cmet.2010.03.015 Han, 2013, The role of PTPN13 in invasion and metastasis of lung squamous cell carcinoma, Exp. Mol. Pathol., 95, 270, 10.1016/j.yexmp.2013.07.008 Han, 2013, Stat3 inhibits PTPN13 expression in squamous cell lung carcinoma through recruitment of HDAC5, Biomed. Res. Int., 468963 Hanada, 1998, Selective suppression of stress-activated protein kinase pathway by protein phosphatase 2C in mammalian cells, FEBS Lett., 437, 172, 10.1016/S0014-5793(98)01229-0 Hanada, 2001, Regulation of the TAK1 signaling pathway by protein phosphatase 2C, J. Biol. Chem., 276, 5753, 10.1074/jbc.M007773200 Hanahan, 2011, Hallmarks of cancer: the next generation, Cell, 144, 646, 10.1016/j.cell.2011.02.013 Hannon, 1994, KAP: a dual specificity phosphatase that interacts with cyclin-dependent kinases, Proc. Natl. Acad. Sci. U. S. A., 91, 1731, 10.1073/pnas.91.5.1731 Hao, 2007, BRCA1-IRIS activates cyclin D1 expression in breast cancer cells by downregulating the JNK phosphatase DUSP3/VHR, Int. J. Cancer, 121, 39, 10.1002/ijc.22597 Hao, 2015, Disruption of a regulatory loop between DUSP1 and p53 contributes to hepatocellular carcinoma development and progression, J. Hepatol., 62, 1278, 10.1016/j.jhep.2014.12.033 Hassan, 2010, Structural and functional analysis of human prostatic acid phosphatase, Expert Rev. Anticancer Ther., 10, 1055, 10.1586/era.10.46 Hausmann, 2015, ILKAP, ILK and PINCH1 control cell survival of p53-wildtype glioblastoma cells after irradiation, Oncotarget, 6, 34592, 10.18632/oncotarget.5423 Hein, 2016, PR55α subunit of protein phosphatase 2A supports the tumorigenic and metastatic potential of pancreatic cancer cells by sustaining hyperactive oncogenic signaling, Cancer Res., 76, 2243, 10.1158/0008-5472.CAN-15-2119 Hellberg, 2002, Expression of the receptor protein-tyrosine phosphatase, PTPmu, restores E-cadherin-dependent adhesion in human prostate carcinoma cells, J. Biol. Chem., 277, 11165, 10.1074/jbc.M112157200 Henkens, 2008, Cervix carcinoma is associated with an up-regulation and nuclear localization of the dual-specificity protein phosphatase VHR, BMC Cancer, 8, 147, 10.1186/1471-2407-8-147 Hijiya, 2016, Genomic loss of DUSP4 contributes to the progression of intraepithelial neoplasm of pancreas to invasive carcinoma, Cancer Res., 76, 2612, 10.1158/0008-5472.CAN-15-1846 Hiscox, 1999, Association of the HGF/SF receptor, c-met, with the cell-surface adhesion molecule, E-cadherin, and catenins in human tumor cells, Biochem. Biophys. Res. Commun., 261, 406, 10.1006/bbrc.1999.1002 Holness, 2003, Regulation of pyruvate dehydrogenase complex activity by reversible phosphorylation, Biochem. Soc. Trans., 31, 1143, 10.1042/bst0311143 Hong, 2015, LB100, a small molecule inhibitor of PP2A with potent chemo- and radio-sensitizing potential, Cancer Biol. Ther., 16, 821, 10.1080/15384047.2015.1040961 Hong, 2016, miR-96 promotes cell proliferation, migration and invasion by targeting PTPN9 in breast cancer, Sci. Rep., 6, 37421, 10.1038/srep37421 Hoornaert, 2003, MAPK phosphatase DUSP16/MKP-7, a candidate tumor suppressor for chromosome region 12p 12–13, reduces BCR-ABL-induced transformation, Oncogene, 22, 7728, 10.1038/sj.onc.1207089 Hoover, 2009, Impaired PTPN13 phosphatase activity in spontaneous or HPV-induced squamous cell carcinomas potentiates oncogene signaling through the MAP kinase pathway, Oncogene, 28, 3960, 10.1038/onc.2009.251 Horita, 2008, Suppression of the invasive capacity of rat ascites hepatoma cells by knockdown of Slingshot or LIM kinase, J. Biol. Chem., 283, 6013, 10.1074/jbc.M706538200 Hou, 2012, FKBP5 as a selection biomarker for gemcitabine and Akt inhibitors in treatment of pancreatic cancer, PLoS One, 7, e36252, 10.1371/journal.pone.0036252 Hou, 2010, PTPH1 dephosphorylates and cooperates with p38gamma MAPK to increase ras oncogenesis through PDZ-mediated interaction, Cancer Res., 70, 2901, 10.1158/0008-5472.CAN-09-3229 Hou, 2013, Estrogen-sensitive PTPRO expression represses hepatocellular carcinoma progression by control of STAT3, Hepatology, 57, 678, 10.1002/hep.25980 Houge, 2015, B56δ-related protein phosphatase 2A dysfunction identified in patients with intellectual disability, J. Clin. Invest., 125, 3051, 10.1172/JCI79860 Hoyt, 2007, Cutting edge: selective tyrosine dephosphorylation of interferon-activated nuclear STAT5 by the VHR phosphatase, J. Immunol., 179, 3402, 10.4049/jimmunol.179.6.3402 Hsu, 2013, Methylation of the PTPRO gene in human hepatocellular carcinoma and identification of VCP as its substrate, J. Cell. Biochem., 114, 1810, 10.1002/jcb.24525 Hu, 2006, Association and regulation of heat shock transcription factor 4b with both extracellular signal-regulated kinase mitogen-activated protein kinase and dual-specificity tyrosine phosphatase DUSP26, Mol. Cell. Biol., 26, 3282, 10.1128/MCB.26.8.3282-3294.2006 Hu, 2015, Inhibition of pten deficient castration resistant prostate cancer by targeting of the SET - PP2A signaling axis, Sci. Rep., 5, 15182, 10.1038/srep15182 Hu, 2016, Downregulated expression of PTPN9 contributes to human hepatocellular carcinoma growth and progression, Pathol. Oncol. Res., 22, 555, 10.1007/s12253-015-0038-1 Hua, 2014, The H3K9 methyltransferase G9a is a marker of aggressive ovarian cancer that promotes peritoneal metastasis, Mol. Cancer, 13, 189, 10.1186/1476-4598-13-189 Huang, 1998, Isoenzymes of pyruvate dehydrogenase phosphatase DNA-derived amino acid sequences, expression, and regulation, J. Biol. Chem., 273, 17680, 10.1074/jbc.273.28.17680 Huang, 2013, PTPRO promoter methylation is predictive of poorer outcome for HER2-positive breast cancer: indication for personalized therapy, J. Transl. Med., 11, 245, 10.1186/1479-5876-11-245 Huang, 2013, Fas-associated phosphatase 1 mediates Fas resistance in myeloid progenitor cells expressing the Bcr-abl oncogene, Leuk. Lymphoma, 54, 619, 10.3109/10428194.2012.720979 Hung, 2016, SET antagonist enhances the chemosensitivity of non-small cell lung cancer cells by reactivating protein phosphatase 2A, Oncotarget, 7, 638, 10.18632/oncotarget.6313 Hunt, 2013, On the regulation of protein phosphatase 2A and its role in controlling entry into and exit from mitosis, Adv. Biol. Regul., 53, 173, 10.1016/j.jbior.2013.04.001 Hunter, 2000, Signaling–2000 and beyond, Cell, 100, 113, 10.1016/S0092-8674(00)81688-8 Iervolino, 2006, The receptor-type protein tyrosine phosphatase J antagonizes the biochemical and biological effects of RET-derived oncoproteins, Cancer Res., 66, 6280, 10.1158/0008-5472.CAN-06-0228 Igawa, 2003, Suppression of LNCaP prostate cancer xenograft tumors by a prostate-specific protein tyrosine phosphatase, prostatic acid phosphatase, Prostate, 55, 247, 10.1002/pros.10240 Inazawa, 1996, PTPN13, a fas-associated protein tyrosine phosphatase, is located on the long arm of chromosome 4 at band q21.3, Genomics, 31, 240, 10.1006/geno.1996.0039 Ishibashi, 1992, Expression cloning of a human dual-specificity phosphatase, Proc. Natl. Acad. Sci. U. S. A., 89, 12170, 10.1073/pnas.89.24.12170 Ito, 2000, A truncated isoform of the PP2A B56 subunit promotes cell motility through paxillin phosphorylation, EMBO J., 19, 562, 10.1093/emboj/19.4.562 Ito, 2016, Activation of ERK/IER3/PP2A-B56γ-positive feedback loop in lung adenocarcinoma by allelic deletion of B56γ gene, Oncol. Rep., 35, 2635, 10.3892/or.2016.4677 Iuliano, 2004, The tyrosine phosphatase PTPRJ/DEP-1 genotype affects thyroid carcinogenesis, Oncogene, 23, 8432, 10.1038/sj.onc.1207766 Janssens, 2001, Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling, Biochem. J, 353, 417, 10.1042/bj3530417 Janssens, 2012, The role and therapeutic potential of Ser/Thr phosphatase PP2A in apoptotic signalling networks in human cancer cells, Curr. Mol. Med., 12, 268, 10.2174/156652412799218930 Janssens, 2016, PP2A binds to the LIM domains of lipoma-preferred partner through its PR130/B′′ subunit to regulate cell adhesion and migration, J. Cell Sci., 129, 1605, 10.1242/jcs.175778 Jardin, 2012, Identification of the structural features that mediate binding specificity in the recognition of STAT proteins by dual-specificity phosphatases, J. Biomol. Struct. Dyn., 29, 777, 10.1080/07391102.2012.10507413 Jeong, 2016, Patient derived mutation W257G of PPP2R1A enhances cancer cell migration through SRC-JNK-c-Jun pathway, Sci. Rep., 6, 27391, 10.1038/srep27391 Jiang, 2014, Survival and inflammation promotion effect of PTPRO in fulminant hepatitis is associated with NF-kappaB activation, J. Immunol., 193, 5161, 10.4049/jimmunol.1303354 Jiang, 2015, MicroRNA-3127 promotes cell proliferation and tumorigenicity in hepatocellular carcinoma by disrupting of PI3K/AKT negative regulation, Oncotarget, 6, 6359, 10.18632/oncotarget.3438 Jiang, 2015, miR-93 promotes cell proliferation in gliomas through activation of PI3K/Akt signaling pathway, Oncotarget, 6, 8286, 10.18632/oncotarget.3221 Jin, 2010, PP2A:B56{epsilon}, a substrate of caspase-3, regulates p53-dependent and p53-independent apoptosis during development, J. Biol. Chem., 285, 34493, 10.1074/jbc.M110.169581 Ju, 2016, Scaffold role of DUSP22 in ASK1-MKK7-JNK signaling pathway, PLoS One, 11, e0164259, 10.1371/journal.pone.0164259 Julien, 2011, Inside the human cancer tyrosine phosphatome, Nat. Rev. Cancer, 11, 35, 10.1038/nrc2980 Jung, 2012, Discovery of ALK-PTPN3 gene fusion from human non-small cell lung carcinoma cell line using next generation RNA sequencing, Genes Chromosomes Cancer, 51, 590, 10.1002/gcc.21945 Junttila, 2007, CIP2A inhibits PP2A in human malignancies, Cell, 130, 51, 10.1016/j.cell.2007.04.044 Juszczynski, 2009, BCL6 modulates tonic BCR signaling in diffuse large B-cell lymphomas by repressing the SYK phosphatase, PTPROt, Blood, 114, 5315, 10.1182/blood-2009-02-204362 Kalev, 2012, Loss of PPP2R2A inhibits homologous recombination DNA repair and predicts tumor sensitivity to PARP inhibition, Cancer Res., 72, 6414, 10.1158/0008-5472.CAN-12-1667 Kaplon, 2013, A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence, Nature, 498, 109, 10.1038/nature12154 Karai, 2013, Chromosomal rearrangements of 6p25.3 define a new subtype of lymphomatoid papulosis, Am. J. Surg. Pathol., 37, 1173, 10.1097/PAS.0b013e318282d01e Karlsson, 2015, Loss of protein tyrosine phosphatase, non-receptor type 2 is associated with activation of AKT and tamoxifen resistance in breast cancer, Breast Cancer Res. Treat., 153, 31, 10.1007/s10549-015-3516-y Kaur, 2016, Regulation of protein phosphatase 2A (PP2A) tumor suppressor function by PME-1, Biochem. Soc. Trans., 44, 1683, 10.1042/BST20160161 Kaur, 2015, Protein phosphatase methylesterase-1 (PME-1) expression predicts a favorable clinical outcome in colorectal cancer, Cancer Med., 4, 1798, 10.1002/cam4.541 Kaur, 2016, PP2A inhibitor PME-1 drives kinase inhibitor resistance in glioma cells, Cancer Res., 76, 7001, 10.1158/0008-5472.CAN-16-1134 Kawahara, 2013, Dynamic regulation of extracellular signal-regulated kinase (ERK) by protein phosphatase 2A regulatory subunit B56γ1 in nuclei induces cell migration, PLoS One, 8, e63729, 10.1371/journal.pone.0063729 Keane, 1996, The protein tyrosine phosphatase DEP-1 is induced during differentiation and inhibits growth of breast cancer cells, Cancer Res., 56, 4236 Khanna, 2016, Clinical significance of cancerous inhibitor of protein phosphatase 2A in human cancers, Int. J. Cancer, 138, 525, 10.1002/ijc.29431 Khanna, 2013, Chk1 targeting reactivates PP2A tumor suppressor activity in cancer cells, Cancer Res., 73, 6757, 10.1158/0008-5472.CAN-13-1002 Khor, 2013, DNA methylation profiling revealed promoter hypermethylation-induced silencing of p16, DDAH2 and DUSP1 in primary oral squamous cell carcinoma, Int. J. Med. Sci., 10, 1727, 10.7150/ijms.6884 Kibel, 2004, Expression mapping at 12p 12-13 in advanced prostate carcinoma, Int. J. Cancer, 109, 668, 10.1002/ijc.20060 Kidger, 2017, Dual-specificity phosphatase 5 controls the localized inhibition, propagation, and transforming potential of ERK signaling, Proc. Natl. Acad. Sci. U. S. A., 114, E317, 10.1073/pnas.1614684114 Kim, 1999, Constitutive activation of extracellular signal-regulated kinase in human acute leukemias: combined role of activation of MEK, hyperexpression of extracellular signal-regulated kinase, and downregulation of a phosphatase, PAC1, Blood, 93, 3893, 10.1182/blood.V93.11.3893 Kim, 2002, Gastrin-releasing peptide is a growth factor for human neuroblastomas, Ann. Surg., 235, 621, 10.1097/00000658-200205000-00003 Kim, 2014, The DUSP26 phosphatase activator adenylate kinase 2 regulates FADD phosphorylation and cell growth, Nat. Commun., 5, 3351, 10.1038/ncomms4351 Kim, 2014, Loss of CDC14B expression in clear cell renal cell carcinoma: meta-analysis of microarray data sets, Am. J. Clin. Pathol., 141, 551, 10.1309/AJCP4PE4JPSRGBQS King, 2016, Morphologic features of ALK-negative anaplastic large cell lymphomas with DUSP22 rearrangements, Am. J. Surg. Pathol., 40, 36, 10.1097/PAS.0000000000000500 Kleppe, 2010, Deletion of the protein tyrosine phosphatase gene PTPN2 in T-cell acute lymphoblastic leukemia, Nat. Genet., 42, 530, 10.1038/ng.587 Kleppe, 2011, Mutation analysis of the tyrosine phosphatase PTPN2 in Hodgkin's lymphoma and T-cell non-Hodgkin's lymphoma, Haematologica, 96, 1723, 10.3324/haematol.2011.041921 Kleppe, 2011, PTPN2 negatively regulates oncogenic JAK1 in T-cell acute lymphoblastic leukemia, Blood, 117, 7090, 10.1182/blood-2010-10-314286 Klingler-Hoffmann, 2001, The protein tyrosine phosphatase TCPTP suppresses the tumorigenicity of glioblastoma cells expressing a mutant epidermal growth factor receptor, J. Biol. Chem., 276, 46313, 10.1074/jbc.M106571200 Klingmüller, 1995, Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals, Cell, 80, 729, 10.1016/0092-8674(95)90351-8 Klumpp, 2003, Protein phosphatase type 2C dephosphorylates BAD, Neurochem. Int., 42, 555, 10.1016/S0197-0186(02)00174-2 Kodama, 2016, Transposon mutagenesis identifies genes and cellular processes driving epithelial-mesenchymal transition in hepatocellular carcinoma, Proc. Natl. Acad. Sci. U. S. A., 113, E3384, 10.1073/pnas.1606876113 Koh, 2002, The p21-activated kinase PAK is negatively regulated by POPX1 and POPX2, a pair of serine/threonine phosphatases of the PP2C family, Curr. Biol., 12, 317, 10.1016/S0960-9822(02)00652-8 Kolupaeva, 2013, PP1 and PP2A phosphatases–cooperating partners in modulating retinoblastoma protein activation, FEBS J., 280, 627, 10.1111/j.1742-4658.2012.08511.x Kolupaeva, 2013, The B55α regulatory subunit of protein phosphatase 2A mediates fibroblast growth factor-induced p107 dephosphorylation and growth arrest in chondrocytes, Mol. Cell. Biol., 33, 2865, 10.1128/MCB.01730-12 Kontturi, 1991, Is acid phosphatase (PAP) still justified in the management of prostatic cancer?, Acta Oncol., 30, 169, 10.3109/02841869109092343 Kovalenko, 2000, Site-selective dephosphorylation of the platelet-derived growth factor beta-receptor by the receptor-like protein-tyrosine phosphatase DEP-1, J. Biol. Chem., 275, 16219, 10.1074/jbc.275.21.16219 Kucharska, 2009, Regulation of the inducible nuclear dual-specificity phosphatase DUSP5 by ERK MAPK, Cell. Signal., 21, 1794, 10.1016/j.cellsig.2009.07.015 Kumar, 2004, ILKAP regulates ILK signaling and inhibits anchorage-independent growth, Oncogene, 23, 3454, 10.1038/sj.onc.1207473 Kuo, 2008, Regulation of phosphorylation of Thr-308 of Akt, cell proliferation, and survival by the B55alpha regulatory subunit targeting of the protein phosphatase 2A holoenzyme to Akt, J. Biol. Chem., 283, 1882, 10.1074/jbc.M709585200 Kurimchak, 2013, Activation of p107 by fibroblast growth factor, which is essential for chondrocyte cell cycle exit, is mediated by the protein phosphatase 2A/B55α holoenzyme, Mol. Cell. Biol., 33, 3330, 10.1128/MCB.00082-13 Labes, 1998, A novel phosphatase regulating neurite extension on CNS inhibitors, Mol. Cell. Neurosci., 12, 29, 10.1006/mcne.1998.0692 Laczmanska, 2011, Tyrosine phosphatases as a superfamily of tumor suppressors in colorectal cancer, Acta Biochim. Pol., 58, 467, 10.18388/abp.2011_2212 Laczmanska, 2013, Protein tyrosine phosphatase receptor-like genes are frequently hypermethylated in sporadic colorectal cancer, J. Hum. Genet., 58, 11, 10.1038/jhg.2012.119 Lai, 2012, Overexpression of cyclin-dependent kinase-associated protein phosphatase enhances cell proliferation in renal cancer cells, Urol. Oncol., 30, 871, 10.1016/j.urolonc.2010.09.010 Lai, 2016, The B56γ3 regulatory subunit-containing protein phosphatase 2A outcompetes Akt to regulate p27KIP1 subcellular localization by selectively dephosphorylating phospho-Thr157 of p27KIP1, Oncotarget, 7, 4542, 10.18632/oncotarget.6609 Laine, 2014, Molecular pathways: harnessing E2F1 regulation for prosenescence therapy in p53-defective cancer cells, Clin. Cancer Res., 20, 3644, 10.1158/1078-0432.CCR-13-1942 Lambrecht, 2013, Structure, regulation, and pharmacological modulation of PP2A phosphatases, Methods Mol. Biol., 1053, 283, 10.1007/978-1-62703-562-0_17 Lambrecht, 2017, Loss of protein phosphatase 2A regulatory subunit B56δ promotes spontaneous tumorigenesis in vivo, Oncogene Lammers, 2007, Role of type 2C protein phosphatases in growth regulation and in cellular stress signaling, Crit. Rev. Biochem. Mol. Biol., 42, 437, 10.1080/10409230701693342 Lammers, 2007, Role of PP2Calpha in cell growth, in radio- and chemosensitivity, and in tumorigenicity, Mol. Cancer, 6, 65, 10.1186/1476-4598-6-65 Lee, 2009, Genomic-wide analysis of lymphatic metastasis-associated genes in human hepatocellular carcinoma, World J. Gastroenterol., 15, 356, 10.3748/wjg.15.356 Lee, 2010, DUSP16 is an epigenetically regulated determinant of JNK signalling in Burkitt's lymphoma, Br. J. Cancer, 103, 265, 10.1038/sj.bjc.6605711 Lee, 2017, Targeted disruption of TC-PTP in the proliferative compartment augments STAT3 and AKT signaling and skin tumor development, Sci. Rep., 7, 45077, 10.1038/srep45077 Lee-Hoeflich, 2011, PPM1H is a p27 phosphatase implicated in trastuzumab resistance, Cancer Discov., 1, 326, 10.1158/2159-8290.CD-11-0062 Lessard, 2010, The two faces of PTP1B in cancer, Biochim. Biophys. Acta, 1804, 613, 10.1016/j.bbapap.2009.09.018 Lesueur, 2005, Allelic association of the human homologue of the mouse modifier Ptprj with breast cancer, Hum. Mol. Genet., 14, 2349, 10.1093/hmg/ddi237 Letourneux, 2006, B56-containing PP2A dephosphorylate ERK and their activity is controlled by the early gene IEX-1 and ERK, EMBO J., 25, 727, 10.1038/sj.emboj.7600980 Leung-Hagesteijn, 2001, Modulation of integrin signal transduction by ILKAP, a protein phosphatase 2C associating with the integrin-linked kinase, ILK1, EMBO J., 20, 2160, 10.1093/emboj/20.9.2160 Levea, 2000, PTP LAR. expression compared to prognostic indices in metastatic and non-metastatic breast cancer, Breast Cancer Res. Treat., 64, 221, 10.1023/A:1006410509740 Levinson, 1978, Evidence that the transforming gene of avian sarcoma virus encodes a protein kinase associated with a phosphoprotein, Cell, 15, 561, 10.1016/0092-8674(78)90024-7 Li, 1996, The myeloid leukemia-associated protein SET is a potent inhibitor of protein phosphatase 2A, J. Biol. Chem., 271, 11059, 10.1074/jbc.271.19.11059 Li, 2000, Negative regulation of Fas-mediated apoptosis by FAP-1 in human cancer cells, Int. J. Cancer, 87, 473, 10.1002/1097-0215(20000815)87:4<473::AID-IJC3>3.0.CO;2-1 Li, 2010, JNK pathway-associated phosphatase dephosphorylates focal adhesion kinase and suppresses cell migration, J. Biol. Chem., 285, 5472, 10.1074/jbc.M109.060186 Li, 2013, Metal-dependent protein phosphatase 1A functions as an extracellular signal-regulated kinase phosphatase, FEBS J., 280, 2700, 10.1111/febs.12275 Li, 2013, The deubiquitination enzyme USP46 functions as a tumor suppressor by controlling PHLPP-dependent attenuation of Akt signaling in colon cancer, Oncogene, 32, 471, 10.1038/onc.2012.66 Li, 2014, PHLPP is a negative regulator of RAF1, which reduces colorectal cancer cell motility and prevents tumor progression in mice, Gastroenterology, 146, 1301, 10.1053/j.gastro.2014.02.003 Li, 2014, Methylation and decreased expression of SHP-1 are related to disease progression in chronic myelogenous leukemia, Oncol. Rep., 31, 2438, 10.3892/or.2014.3098 Li, 2014, CDKN3 is an independent prognostic factor and promotes ovarian carcinoma cell proliferation in ovarian cancer, Oncol. Rep., 31, 1825, 10.3892/or.2014.3045 Li, 2014, Aberrant PTPRO methylation in tumor tissues as a potential biomarker that predicts clinical outcomes in breast cancer patients, BMC Genet., 15, 67, 10.1186/1471-2156-15-67 Li, 2015, The association between Salt-inducible kinase 2 (SIK2) and gamma isoform of the regulatory subunit B55 of PP2A (B55gamma) contributes to the survival of glioma cells under glucose depletion through inhibiting the phosphorylation of S6K, Cancer Cell Int., 15, 21, 10.1186/s12935-015-0164-6 Li, 2015, Protein tyrosine phosphatase PTPN3 inhibits lung cancer cell proliferation and migration by promoting EGFR endocytic degradation, Oncogene, 34, 3791, 10.1038/onc.2014.312 Li, 2015, Loss of PTPN12 stimulates progression of erbB2-dependent breast cancer by enhancing cell survival, migration, and epithelial-to-mesenchymal transition, Mol. Cell. Biol., 35, 4069, 10.1128/MCB.00741-15 Li, 2015, KAP regulates ROCK2 and Cdk2 in an RNA-activated glioblastoma invasion pathway, Oncogene, 34, 1432, 10.1038/onc.2014.49 Li, 2015, Methylation profiling of 48 candidate genes in tumor and matched normal tissues from breast cancer patients, Breast Cancer Res. Treat., 149, 767, 10.1007/s10549-015-3276-8 Li, 2016, Methylation analysis of plasma cell-free DNA for breast cancer early detection using bisulfite next-generation sequencing, Tumour Biol., 37, 13111, 10.1007/s13277-016-5190-z Li, 2017, Knockdown of cyclin-dependent kinase inhibitor-3 inhibits proliferation and invasion in human gastric cancer cells, Oncol. Res., 25, 721, 10.3727/096504016X14772375848616 Liao, 2003, Down-regulation of the dual-specificity phosphatase MKP-1 suppresses tumorigenicity of pancreatic cancer cells, Gastroenterology, 124, 1830, 10.1016/S0016-5085(03)00398-6 Lin, 1996, Tyrosine phosphorylation of a 185kDa phosphoprotein (pp185) inversely correlates with the cellular activity of human prostatic acid phosphatase, Biochem. Biophys. Res. Commun., 226, 206, 10.1006/bbrc.1996.1334 Lin, 2001, Decreased expression of cellular prostatic acid phosphatase increases tumorigenicity of human prostate cancer cells, J. Urol., 166, 1943, 10.1016/S0022-5347(05)65725-4 Lin, 2006, PPM1A functions as a Smad phosphatase to terminate TGFbeta signaling, Cell, 125, 915, 10.1016/j.cell.2006.03.044 Lin, 2011, Suppression of dual-specificity phosphatase-2 by hypoxia increases chemoresistance and malignancy in human cancer cells, J. Clin. Invest., 121, 1905, 10.1172/JCI44362 Liu, 2012, Regulation of c-Myc protein abundance by a protein phosphatase 2A-glycogen synthase kinase 3β-negative feedback pathway, Genes Cancer, 3, 23, 10.1177/1947601912448067 Liu, 2007, Microtubule disruption and tumor suppression by mitogen-activated protein kinase phosphatase 4, Cancer Res., 67, 10711, 10.1158/0008-5472.CAN-07-1968 Liu, 2008, Homozygous deletions and recurrent amplifications implicate new genes involved in prostate cancer, Neoplasia, 10, 897, 10.1593/neo.08428 Liu, 2009, Loss of PHLPP expression in colon cancer: role in proliferation and tumorigenesis, Oncogene, 28, 994, 10.1038/onc.2008.450 Liu, 2010, Identifying mRNA targets of microRNA dysregulated in cancer: with application to clear cell Renal Cell Carcinoma, BMC Syst. Biol., 4, 51, 10.1186/1752-0509-4-51 Liu, 2011, PHLPP-mediated dephosphorylation of S6K1 inhibits protein translation and cell growth, Mol. Cell. Biol., 31, 4917, 10.1128/MCB.05799-11 Liu, 2013, PTPN14 interacts with and negatively regulates the oncogenic function of YAP, Oncogene, 32, 1266, 10.1038/onc.2012.147 Liu, 2013, Novel sorafenib analogues induce apoptosis through SHP-1 dependent STAT3 inactivation in human breast cancer cells, Breast Cancer Res., 15, R63, 10.1186/bcr3457 Liu, 2015, Protein tyrosine phosphatase receptor type O expression in the tumor niche correlates with reduced tumor growth, angiogenesis, circulating tumor cells and metastasis of breast cancer, Oncol. Rep., 33, 1908, 10.3892/or.2015.3772 Liu, 2015, Overexpression of PP2A inhibitor SET oncoprotein is associated with tumor progression and poor prognosis in human non-small cell lung cancer, Oncotarget, 6, 14913, 10.18632/oncotarget.3818 Liu, 2016, Hepatitis B virus X protein amplifies TGF-βpromotion on HCC motility through down-regulating PPM1a, Oncotarget, 7, 33125, 10.18632/oncotarget.8884 Liu, 2016, HEATR1 negatively regulates Akt to help sensitize pancreatic cancer cells to chemotherapy, Cancer Res., 76, 572, 10.1158/0008-5472.CAN-15-0671 Liu, 2017, Promoter methylation attenuates SHP1 expression and function in patients with primary central nervous system lymphoma, Oncol. Rep., 37, 887, 10.3892/or.2016.5308 Liu, 2017, Sequential combination of docetaxel with a SHP-1 agonist enhanced suppression of p-STAT3 signaling and apoptosis in triple negative breast cancer cells, J. Mol. Med. (Berl) Liu, 2017, Sorafenib analogue SC-60 induces apoptosis through the SHP-1/STAT3 pathway and enhances docetaxel cytotoxicity in triple-negative breast cancer cells, Mol. Oncol., 11, 266, 10.1002/1878-0261.12033 Loda, 1996, Expression of mitogen-activated protein kinase phosphatase-1 in the early phases of human epithelial carcinogenesis, Am. J. Pathol., 149, 1553 Loor, 1981, Expression of prostatic acid phosphatase in human prostate cancer, Cancer Lett., 14, 63, 10.1016/0304-3835(81)90010-0 Lorenzato, 2016, The integrin-linked kinase-associated phosphatase (ILKAP) is a regulatory hub of ovarian cancer cell susceptibility to platinum drugs, Eur. J. Cancer, 60, 59, 10.1016/j.ejca.2016.02.022 Lorsbach, 2001, The role of the AML1 transcription factor in leukemogenesis, Int. J. Hematol., 74, 258, 10.1007/BF02982058 Lu, 2008, Functional diversity of mammalian type 2C protein phosphatase isoforms: new tales from an old family, Clin. Exp. Pharmacol. Physiol., 35, 107, 10.1111/j.1440-1681.2007.04843.x Lu, 2007, T-cell protein tyrosine phosphatase, distinctively expressed in activated-B-cell-like diffuse large B-cell lymphomas, is the nuclear phosphatase of STAT6, Mol. Cell. Biol., 27, 2166, 10.1128/MCB.01234-06 Lu, 2014, PPM1A is a RelA phosphatase with tumor suppressor-like activity, Oncogene, 33, 2918, 10.1038/onc.2013.246 Lucci, 2010, Expression profile of tyrosine phosphatases in HER2 breast cancer cells and tumors, Cell. Oncol., 32, 361 Luechapanichkul, 2013, Specificity profiling of dual specificity phosphatase vaccinia VH1-related (VHR) reveals two distinct substrate binding modes, J. Biol. Chem., 288, 6498, 10.1074/jbc.M112.449611 Lui, 2014, Frequent mutation of receptor protein tyrosine phosphatases provides a mechanism for STAT3 hyperactivation in head and neck cancer, Proc. Natl. Acad. Sci. U. S. A., 111, 1114, 10.1073/pnas.1319551111 Luo, 2014, Decreased expression of PTPN12 correlates with tumor recurrence and poor survival of patients with hepatocellular carcinoma, PLoS One, 9, e85592, 10.1371/journal.pone.0085592 Luo, 2015, MicroRNA-328 enhances cellular motility through posttranscriptional regulation of PTPRJ in human hepatocellular carcinoma, Onco Targets Ther., 8, 3159 Lv, 2015, High PHLPP expression is associated with better prognosis in patients with resected lung adenocarcinoma, BMC Cancer, 15, 687, 10.1186/s12885-015-1711-1 Mélard, 2016, Molecular alterations and tumor suppressive function of the DUSP22 (Dual Specificity Phosphatase 22) gene in peripheral T-cell lymphoma subtypes, Oncotarget, 7, 68734, 10.18632/oncotarget.11930 Magi-Galluzzi, 1997, Mitogen-activated protein kinase phosphatase 1 is overexpressed in prostate cancers and is inversely related to apoptosis, Lab. Invest., 76, 37 Malentacchi, 2005, Up-regulated expression of low molecular weight protein tyrosine phosphatases in different human cancers, Biochem. Biophys. Res. Commun., 334, 875, 10.1016/j.bbrc.2005.06.176 Manchado, 2010, Targeting mitotic exit leads to tumor regression in vivo: modulation by Cdk1, Mastl, and the PP2A/B55α,δ phosphatase, Cancer Cell, 18, 641, 10.1016/j.ccr.2010.10.028 Mandl, 2005, Specific inactivation and nuclear anchoring of extracellular signal-regulated kinase 2 by the inducible dual-specificity protein phosphatase DUSP5, Mol. Cell. Biol., 25, 1830, 10.1128/MCB.25.5.1830-1845.2005 Mannava, 2012, PP2A-B56α controls oncogene-induced senescence in normal and tumor human melanocytic cells, Oncogene, 31, 1484, 10.1038/onc.2011.339 Manzano, 2002, CL100 expression is down-regulated in advanced epithelial ovarian cancer and its re-expression decreases its malignant potential, Oncogene, 21, 4435, 10.1038/sj.onc.1205542 Marchetti, 2004, Inducible expression of a MAP kinase phosphatase-3-GFP chimera specifically blunts fibroblast growth and ras-dependent tumor formation in nude mice, J. Cell. Physiol., 199, 441, 10.1002/jcp.10465 Martin, 2011, Identification of PTPsigma as an autophagic phosphatase, J. Cell Sci., 124, 812, 10.1242/jcs.080341 Martin, 2013, PP2A regulatory subunit Bα controls endothelial contractility and vessel lumen integrity via regulation of HDAC7, EMBO J., 32, 2491, 10.1038/emboj.2013.187 Mason, 2014, Functional characterization of CFI-400945, a Polo-like kinase 4 inhibitor, as a potential anticancer agent, Cancer Cell, 26, 163, 10.1016/j.ccr.2014.05.006 Mattila, 2008, The protein tyrosine phosphatase TCPTP controls VEGFR2 signalling, J. Cell Sci., 121, 3570, 10.1242/jcs.031898 Mattila, 2010, Inhibition of receptor tyrosine kinase signalling by small molecule agonist of T-cell protein tyrosine phosphatase, BMC Cancer, 10, 7, 10.1186/1471-2407-10-7 Mazumdar, 2016, Analysis of phosphatases in ER-negative breast cancers identifies DUSP4 as a critical regulator of growth and invasion, Breast Cancer Res. Treat., 158, 441, 10.1007/s10549-016-3892-y McArdle, 2001, Protein tyrosine phosphatase genes downregulated in melanoma, J. Invest. Dermatol., 117, 1255, 10.1046/j.0022-202x.2001.01534.x McCabe, 2015, Mechanistic rationale to target PTEN-deficient tumor cells with inhibitors of the DNA damage response kinase ATM, Cancer Res., 75, 2159, 10.1158/0008-5472.CAN-14-3502 McConechy, 2011, Subtype-specific mutation of PPP2R1A in endometrial and ovarian carcinomas, J. Pathol., 223, 567, 10.1002/path.2848 McCorkle, 2014, The metastasis suppressor NME1 regulates expression of genes linked to metastasis and patient outcome in melanoma and breast carcinoma, Cancer Genomics Proteomics, 11, 175 Meehan, 2012, Protein tyrosine phosphatase receptor delta acts as a neuroblastoma tumor suppressor by destabilizing the aurora kinase A oncogene, Mol. Cancer, 11, 6, 10.1186/1476-4598-11-6 Mendes-Pereira, 2009, Synthetic lethal targeting of PTEN mutant cells with PARP inhibitors, EMBO Mol. Med., 1, 315, 10.1002/emmm.200900041 Mendes-Pereira, 2012, NLK is a novel therapeutic target for PTEN deficient tumour cells, PLoS One, 7, e47249, 10.1371/journal.pone.0047249 Meng, 1998, Tyrosine phosphorylation of c-ErbB-2 is regulated by the cellular form of prostatic acid phosphatase in human prostate cancer cells, J. Biol. Chem., 273, 22096, 10.1074/jbc.273.34.22096 Menigatti, 2009, The protein tyrosine phosphatase receptor type R gene is an early and frequent target of silencing in human colorectal tumorigenesis, Mol. Cancer, 8, 124, 10.1186/1476-4598-8-124 Mereniuk, 2013, Synthetic lethal targeting of PTEN-deficient cancer cells using selective disruption of polynucleotide kinase/phosphatase, Mol. Cancer Ther., 12, 2135, 10.1158/1535-7163.MCT-12-1093 Mereniuk, 2012, Genetic screening for synthetic lethal partners of polynucleotide kinase/phosphatase: potential for targeting SHP-1-depleted cancers, Cancer Res., 72, 5934, 10.1158/0008-5472.CAN-12-0939 Meyer, 2014, Tyrosine phosphatase PTPalpha contributes to HER2-evoked breast tumor initiation and maintenance, Oncogene, 33, 398, 10.1038/onc.2012.585 Michaloglou, 2013, The tyrosine phosphatase PTPN14 is a negative regulator of YAP activity, PLoS One, 8, e61916, 10.1371/journal.pone.0061916 Mita, 2010, Missense polymorphisms of PTPRJ and PTPN13 genes affect susceptibility to a variety of human cancers, J. Cancer Res. Clin. Oncol., 136, 249, 10.1007/s00432-009-0656-7 Molina, 2012, PTEN, NHERF1 and PHLPP form a tumor suppressor network that is disabled in glioblastoma, Oncogene, 31, 1264, 10.1038/onc.2011.324 Moncho-Amor, 2011, DUSP1/MKP1 promotes angiogenesis, invasion and metastasis in non-small-cell lung cancer, Oncogene, 30, 668, 10.1038/onc.2010.449 Moore, 1991, Evidence that AMP triggers phosphorylation as well as direct allosteric activation of rat liver AMP-activated protein kinase. A sensitive mechanism to protect the cell against ATP depletion, Eur. J. Biochem., 199, 691, 10.1111/j.1432-1033.1991.tb16172.x Mori, 2004, Identification of genes uniquely involved in frequent microsatellite instability colon carcinogenesis by expression profiling combined with epigenetic scanning, Cancer Res., 64, 2434, 10.1158/0008-5472.CAN-03-3508 Morris, 2011, Genomic dissection of the epidermal growth factor receptor (EGFR)/PI3K pathway reveals frequent deletion of the EGFR phosphatase PTPRS in head and neck cancers, Proc. Natl. Acad. Sci. U. S. A., 108, 19024, 10.1073/pnas.1111963108 Mosca, 2013, Genome-wide analysis of primary plasma cell leukemia identifies recurrent imbalances associated with changes in transcriptional profiles, Am. J. Hematol., 88, 16, 10.1002/ajh.23339 Mosinger, 1992, Cloning and characterization of a mouse cDNA encoding a cytoplasmic protein-tyrosine-phosphatase, Proc. Natl. Acad. Sci. U. S. A., 89, 499, 10.1073/pnas.89.2.499 Motiwala, 2003, Suppression of the protein tyrosine phosphatase receptor type O gene (PTPRO) by methylation in hepatocellular carcinomas, Oncogene, 22, 6319, 10.1038/sj.onc.1206750 Motiwala, 2004, Protein tyrosine phosphatase receptor-type O (PTPRO) exhibits characteristics of a candidate tumor suppressor in human lung cancer, Proc. Natl. Acad. Sci. U. S. A., 101, 13844, 10.1073/pnas.0405451101 Motiwala, 2007, Methylation and silencing of protein tyrosine phosphatase receptor type O in chronic lymphocytic leukemia, Clin. Cancer Res., 13, 3174, 10.1158/1078-0432.CCR-06-1720 Motiwala, 2009, PTPROt inactivates the oncogenic fusion protein BCR/ABL and suppresses transformation of K562 cells, J. Biol. Chem., 284, 455, 10.1074/jbc.M802840200 Motiwala, 2015, PTPROt-mediated regulation of p53/Foxm1 suppresses leukemic phenotype in a CLL mouse model, Leukemia, 29, 1350, 10.1038/leu.2014.341 Mourton, 2001, The PTPmu protein-tyrosine phosphatase binds and recruits the scaffolding protein RACK1 to cell-cell contacts, J. Biol. Chem., 276, 14896, 10.1074/jbc.M010823200 Muda, 1997, Molecular cloning and functional characterization of a novel mitogen-activated protein kinase phosphatase, MKP-4, J. Biol. Chem., 272, 5141, 10.1074/jbc.272.8.5141 Muggerud, 2010, Frequent aberrant DNA methylation of ABCB1, FOXC1, PPP2R2B and PTEN in ductal carcinoma in situ and early invasive breast cancer, Breast Cancer Res., 12, R3, 10.1186/bcr2466 Munkley, 2015, Androgen-regulation of the protein tyrosine phosphatase PTPRR activates ERK1/2 signalling in prostate cancer cells, BMC Cancer, 15, 9, 10.1186/s12885-015-1012-8 Nagao, 1989, Role of protein phosphatases in malignant transformation, Princess Takamatsu Symp., 20, 177 Nagendra, 2012, PPP2R1A mutations are common in the serous type of endometrial cancer, Mol. Carcinog., 51, 826, 10.1002/mc.20850 Nakamura, 2002, A novel low-molecular-mass dual-specificity phosphatase, LDP-2, with a naturally occurring substitution that affects substrate specificity, J. Biochem., 132, 463, 10.1093/oxfordjournals.jbchem.a003244 Nakamura, 2003, Novel tumor suppressor loci on 6q22-23 in primary central nervous system lymphomas, Cancer Res., 63, 737 Nalepa, 2013, The tumor suppressor CDKN3 controls mitosis, J. Cell Biol., 201, 997, 10.1083/jcb.201205125 Nassar, 2015, Genomic landscape of carcinogen-induced and genetically induced mouse skin squamous cell carcinoma, Nat. Med., 21, 946, 10.1038/nm.3878 Negro, 2012, Overexpression of the autoimmunity-associated phosphatase PTPN22 promotes survival of antigen-stimulated CLL cells by selectively activating AKT, Blood, 119, 6278, 10.1182/blood-2012-01-403162 Niedergethmann, 2007, Gene expression profiling of liver metastases and tumour invasion in pancreatic cancer using an orthotopic SCID mouse model, Br. J. Cancer, 97, 1432, 10.1038/sj.bjc.6604031 Nikitina, 2017, Novel RNA biomarkers of prostate cancer revealed by RNA-seq analysis of formalin-fixed samples obtained from Russian patients, Oncotarget, 8, 32990, 10.18632/oncotarget.16518 Nitsche, 2012, The phosphatase PHLPP1 regulates Akt2, promotes pancreatic cancer cell death, and inhibits tumor formation, Gastroenterology, 142, 377, 10.1053/j.gastro.2011.10.026 Niu, 2009, Genetic polymorphisms in the PTPN13 gene and risk of squamous cell carcinoma of head and neck, Carcinogenesis, 30, 2053, 10.1093/carcin/bgp265 Nobumori, 2013, B56γ tumor-associated mutations provide new mechanisms for B56γ-PP2A tumor suppressor activity, Mol. Cancer Res., 11, 995, 10.1158/1541-7786.MCR-12-0633 Novellino, 2008, PTPRK negatively regulates transcriptional activity of wild type and mutated oncogenic beta-catenin and affects membrane distribution of beta-catenin/E-cadherin complexes in cancer cells, Cell. Signal., 20, 872, 10.1016/j.cellsig.2007.12.024 Nunes-Xavier, 2011, Dual-specificity MAP kinase phosphatases as targets of cancer treatment, Anticancer Agents Med. Chem., 11, 109, 10.2174/187152011794941190 Oczko-Wojciechowska, 2017, Differences in the transcriptome of medullary thyroid cancer regarding the status and type of RET gene mutations, Sci. Rep., 7, 42074, 10.1038/srep42074 Ofek, 2003, Cell cycle regulation and p53 activation by protein phosphatase 2C alpha, J. Biol. Chem., 278, 14299, 10.1074/jbc.M211699200 Ohtaka, 2017, Low-molecular-weight protein tyrosine phosphatase expression as a prognostic factor for men with metastatic hormone-naïve prostate cancer, Urol. Oncol., 10.1016/j.urolonc.2017.05.019 Oka, 2001, Reduction of hematopoietic cell-specific tyrosine phosphatase SHP-1 gene expression in natural killer cell lymphoma and various types of lymphomas/leukemias: combination analysis with cDNA expression array and tissue microarray, Am. J. Pathol., 159, 1495, 10.1016/S0002-9440(10)62535-7 Oka, 2002, Gene silencing of the tyrosine phosphatase SHP1 gene by aberrant methylation in leukemias/lymphomas, Cancer Res., 62, 6390 Okudela, 2009, Down-regulation of DUSP6 expression in lung cancer: its mechanism and potential role in carcinogenesis, Am. J. Pathol., 175, 867, 10.2353/ajpath.2009.080489 Omerovic, 2010, Phosphatome profiling reveals PTPN2, PTPRJ and PTEN as potent negative regulators of PKB/Akt activation in Ras-mutated cancer cells, Biochem. J., 426, 65, 10.1042/BJ20091413 Ortega-Paino, 2008, Functionally associated targets in mantle cell lymphoma as defined by DNA microarrays and RNA interference, Blood, 111, 1617, 10.1182/blood-2007-02-068791 Ortiz, 2014, Loss of the tyrosine phosphatase PTPRD leads to aberrant STAT3 activation and promotes gliomagenesis, Proc. Natl. Acad. Sci. U. S. A., 111, 8149, 10.1073/pnas.1401952111 Ortuso, 2013, Discovery of PTPRJ agonist peptides that effectively inhibit in vitro cancer cell proliferation and tube formation, ACS Chem. Biol., 8, 1497, 10.1021/cb3007192 Ory, 2003, Protein phosphatase 2A positively regulates Ras signaling by dephosphorylating KSR1 and Raf-1 on critical 14-3-3 binding sites, Curr. Biol., 13, 1356, 10.1016/S0960-9822(03)00535-9 Ouillette, 2008, Integrated genomic profiling of chronic lymphocytic leukemia identifies subtypes of deletion 13q14, Cancer Res., 68, 1012, 10.1158/0008-5472.CAN-07-3105 Paduano, 2012, Isolation and functional characterization of peptide agonists of PTPRJ, a tyrosine phosphatase receptor endowed with tumor suppressor activity, ACS Chem. Biol., 7, 1666, 10.1021/cb300281t Paduano, 2013, Protein tyrosine phosphatase PTPRJ is negatively regulated by microRNA-328, FEBS J., 280, 401, 10.1111/j.1742-4658.2012.08624.x Palka, 2003, Hepatocyte growth factor receptor tyrosine kinase met is a substrate of the receptor protein-tyrosine phosphatase DEP-1, J. Biol. Chem., 278, 5728, 10.1074/jbc.M210656200 Pallas, 1990, Polyoma small and middle T antigens and SV40 small t antigen form stable complexes with protein phosphatase 2A, Cell, 60, 167, 10.1016/0092-8674(90)90726-U Parrilla Castellar, 2014, ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes, Blood, 124, 1473, 10.1182/blood-2014-04-571091 Pasquo, 2012, Structural stability of human protein tyrosine phosphatase ρ catalytic domain: effect of point mutations, PLoS One, 7, e32555, 10.1371/journal.pone.0032555 Patterson, 2009, Dual-specificity phosphatases: critical regulators with diverse cellular targets, Biochem. J., 418, 475, 10.1042/BJ20082234 Patterson, 2010, DUSP26 negatively affects the proliferation of epithelial cells, an effect not mediated by dephosphorylation of MAPKs, Biochim. Biophys. Acta, 1803, 1003, 10.1016/j.bbamcr.2010.03.014 Pavic, 2015, VHR/DUSP3 phosphatase: structure, function and regulation, FEBS J., 282, 1871, 10.1111/febs.13263 Pedersen, 2017, DUSP22 and TP63 rearrangements predict outcome of ALK-negative anaplastic large cell lymphoma: a Danish cohort study, Blood, 130, 554, 10.1182/blood-2016-12-755496 Pei, 2009, FKBP51 affects cancer cell response to chemotherapy by negatively regulating Akt, Cancer Cell, 16, 259, 10.1016/j.ccr.2009.07.016 Perander, 2017, Regulation of atypical MAP kinases ERK3 and ERK4 by the phosphatase DUSP2, Sci. Rep., 7, 43471, 10.1038/srep43471 Perrotti, 2013, Protein phosphatase 2A: a target for anticancer therapy, Lancet Oncol., 14, e229, 10.1016/S1470-2045(12)70558-2 Persson, 2004, Site-selective regulation of platelet-derived growth factor beta receptor tyrosine phosphorylation by T-cell protein tyrosine phosphatase, Mol. Cell. Biol., 24, 2190, 10.1128/MCB.24.5.2190-2201.2004 Petermann, 2011, Loss of the protein-tyrosine phosphatase DEP-1/PTPRJ drives meningioma cell motility, Brain Pathol., 21, 405, 10.1111/j.1750-3639.2010.00464.x Petritsch, 2000, TGF-beta inhibits p70 S6 kinase via protein phosphatase 2A to induce G(1) arrest, Genes Dev., 14, 3093, 10.1101/gad.854200 Peyser, 2015, Loss-of-function PTPRD mutations lead to increased STAT3 activation and sensitivity to STAT3 inhibition in head and neck cancer, PLoS One, 10, e0135750, 10.1371/journal.pone.0135750 Peyser, 2016, Frequent promoter hypermethylation of PTPRT increases STAT3 activation and sensitivity to STAT3 inhibition in head and neck cancer, Oncogene, 35, 1163, 10.1038/onc.2015.171 Phillips-Mason, 2008, BCCIP associates with the receptor protein tyrosine phosphatase PTPmu, J. Cell. Biochem., 105, 1059, 10.1002/jcb.21907 Phillips-Mason, 2011, Identification of phospholipase C gamma1 as a protein tyrosine phosphatase mu substrate that regulates cell migration, J. Cell. Biochem., 112, 39, 10.1002/jcb.22710 Plutzky, 1992, Chromosomal localization of an SH2-containing tyrosine phosphatase (PTPN6), Genomics, 13, 869, 10.1016/0888-7543(92)90172-O Poon, 1995, Dephosphorylation of Cdk2 Thr160 by the cyclin-dependent kinase-interacting phosphatase KAP in the absence of cyclin, Science, 270, 90, 10.1126/science.270.5233.90 Prabhu, 2015, Ras-mediated modulation of pyruvate dehydrogenase activity regulates mitochondrial reserve capacity and contributes to glioblastoma tumorigenesis, Neuro Oncol., 17, 1220, 10.1093/neuonc/nou369 Prajapati, 2004, Protein phosphatase 2Cbeta association with the IkappaB kinase complex is involved in regulating NF-kappaB activity, J. Biol. Chem., 279, 1739, 10.1074/jbc.M306273200 Purdie, 2007, Allelic imbalances and microdeletions affecting the PTPRD gene in cutaneous squamous cell carcinomas detected using single nucleotide polymorphism microarray analysis, Genes Chromosomes Cancer, 46, 661, 10.1002/gcc.20447 Puustinen, 2009, PME-1 protects extracellular signal-regulated kinase pathway activity from protein phosphatase 2A-mediated inactivation in human malignant glioma, Cancer Res., 69, 2870, 10.1158/0008-5472.CAN-08-2760 Qi, 2016, Protein tyrosine phosphatase PTPRB regulates Src phosphorylation and tumour progression in NSCLC, Clin. Exp. Pharmacol. Physiol., 43, 1004, 10.1111/1440-1681.12610 Qiao, 2010, Mst1 is an interacting protein that mediates PHLPPs' induced apoptosis, Mol. Cell, 38, 512, 10.1016/j.molcel.2010.03.017 Qiao, 2016, Loss of protein tyrosine phosphatase receptor J expression predicts an aggressive clinical course in patients with esophageal squamous cell carcinoma, Pathol. Oncol. Res., 22, 541, 10.1007/s12253-015-0036-3 Qin, 2017, SNORA74B gene silencing inhibits gallbladder cancer cells by inducing PHLPP and suppressing Akt/mTOR signaling, Oncotarget, 8, 19980, 10.18632/oncotarget.15301 Qiu, 2015, Protein phosphatase PHLPP induces cell apoptosis and exerts anticancer activity by inhibiting Survivin phosphorylation and nuclear export in gallbladder cancer, Oncotarget, 6, 19148, 10.18632/oncotarget.3721 Quintero, 2007, Prostatic acid phosphatase is not a prostate specific target, Cancer Res., 67, 6549, 10.1158/0008-5472.CAN-07-1651 Quintero, 2013, Transmembrane prostatic acid phosphatase (TMPAP) interacts with snapin and deficient mice develop prostate adenocarcinoma, PLoS One, 8, e73072, 10.1371/journal.pone.0073072 Révillion, 2009, Expression of the putative tumor suppressor gene PTPN13/PTPL1 is an independent prognostic marker for overall survival in breast cancer, Int. J. Cancer, 124, 638, 10.1002/ijc.23989 Rahman, 2013, PPP2R1A mutation is a rare event in ovarian carcinoma across histological subtypes, Anticancer Res., 33, 113 Rahmouni, 2006, Loss of the VHR dual-specific phosphatase causes cell-cycle arrest and senescence, Nat. Cell Biol., 8, 524, 10.1038/ncb1398 Ramaswamy, 2009, Estrogen-mediated suppression of the gene encoding protein tyrosine phosphatase PTPRO in human breast cancer: mechanism and role in tamoxifen sensitivity, Mol. Endocrinol., 23, 176, 10.1210/me.2008-0211 Ramesh, 2015, A novel phosphatidic acid-protein-tyrosine phosphatase D2 axis is essential for ERBB2 signaling in mammary epithelial cells, J. Biol. Chem., 290, 9646, 10.1074/jbc.M114.627968 Ramnarain, 2006, Differential gene expression analysis reveals generation of an autocrine loop by a mutant epidermal growth factor receptor in glioma cells, Cancer Res., 66, 867, 10.1158/0008-5472.CAN-05-2753 Rauhala, 2005, Dual-specificity phosphatase 1 and serum/glucocorticoid-regulated kinase are downregulated in prostate cancer, Int. J. Cancer, 117, 738, 10.1002/ijc.21270 Rebay, 2015, Multiple functions of the eya phosphotyrosine phosphatase, Mol. Cell. Biol., 36, 668, 10.1128/MCB.00976-15 Reid, 2013, The B55α subunit of PP2A drives a p53-dependent metabolic adaptation to glutamine deprivation, Mol. Cell, 50, 200, 10.1016/j.molcel.2013.02.008 Reif, 1973, Acid phosphatase isozymes in cancer of the prostate, Cancer, 31, 689, 10.1002/1097-0142(197303)31:3<689::AID-CNCR2820310331>3.0.CO;2-F Rellinger, 2015, Silencing gastrin-releasing peptide receptor suppresses key regulators of aerobic glycolysis in neuroblastoma cells, Pediatr. Blood Cancer, 62, 581, 10.1002/pbc.25348 Reyes, 2014, Pleckstrin homology domain leucine-rich repeat protein phosphatases set the amplitude of receptor tyrosine kinase output, Proc. Natl. Acad. Sci. U. S. A., 111, E3957, 10.1073/pnas.1404221111 Richard, 2016, Combined targeting of SET and tyrosine kinases provides an effective therapeutic approach in human T-cell acute lymphoblastic leukemia, Oncotarget, 7, 84214, 10.18632/oncotarget.12394 Rigacci, 2002, Low Mr phosphotyrosine protein phosphatase associates and dephosphorylates p125 focal adhesion kinase, interfering with cell motility and spreading, J. Biol. Chem., 277, 41631, 10.1074/jbc.M201709200 Rigacci, 2003, LMW-PTP associates and dephosphorylates STAT5 interacting with its C-terminal domain, Biochem. Biophys. Res. Commun., 312, 360, 10.1016/j.bbrc.2003.10.126 Rigacci, 2008, Modulation of STAT5 interaction with LMW-PTP during early megakaryocyte differentiation, Biochemistry, 47, 1482, 10.1021/bi701131e Roberts, 2010, Essential requirement for PP2A inhibition by the oncogenic receptor c-KIT suggests PP2A reactivation as a strategy to treat c-KIT+ cancers, Cancer Res., 70, 5438, 10.1158/0008-5472.CAN-09-2544 Rocher, 2007, Inhibition of B56-containing protein phosphatase 2As by the early response gene IEX-1 leads to control of Akt activity, J. Biol. Chem., 282, 5468, 10.1074/jbc.M609712200 Rojo, 2009, Mitogen-activated protein kinase phosphatase-1 in human breast cancer independently predicts prognosis and is repressed by doxorubicin, Clin. Cancer Res., 15, 3530, 10.1158/1078-0432.CCR-08-2070 Rothschild, 2010, Src inhibitors in lung cancer: current status and future directions, Clin. Lung Cancer, 11, 238, 10.3816/CLC.2010.n.030 Ruediger, 2001, Disruption of protein phosphatase 2A subunit interaction in human cancers with mutations in the A alpha subunit gene, Oncogene, 20, 10, 10.1038/sj.onc.1204059 Ruediger, 2001, Alterations in protein phosphatase 2A subunit interaction in human carcinomas of the lung and colon with mutations in the A beta subunit gene, Oncogene, 20, 1892, 10.1038/sj.onc.1204279 Ruediger, 2011, Human cancer-associated mutations in the Aα subunit of protein phosphatase 2A increase lung cancer incidence in Aα knock-in and knockout mice, Mol. Cell. Biol., 31, 3832, 10.1128/MCB.05744-11 Ruivenkamp, 2003, LOH of PTPRJ occurs early in colorectal cancer and is associated with chromosomal loss of 18q12-21, Oncogene, 22, 3472, 10.1038/sj.onc.1206246 Rushworth, 2014, Dual-specificity phosphatase 5 regulates nuclear ERK activity and suppresses skin cancer by inhibiting mutant Harvey-Ras (HRasQ61L)-driven SerpinB2 expression, Proc. Natl. Acad. Sci. U. S. A., 111, 18267, 10.1073/pnas.1420159112 Ruvolo, 2008, PKR regulates B56(alpha)-mediated BCL2 phosphatase activity in acute lymphoblastic leukemia-derived REH cells, J. Biol. Chem., 283, 35474, 10.1074/jbc.M800951200 Ruvolo, 2011, Low expression of PP2A regulatory subunit B55αα is associated with T308 phosphorylation of AKT and shorter complete remission duration in acute myeloid leukemia patients, Leukemia, 25, 1711, 10.1038/leu.2011.146 Ruvolo, 2014, The protein phosphatase 2A regulatory subunit B55α is a modulator of signaling and microRNA expression in acute myeloid leukemia cells, Biochim. Biophys. Acta, 1843, 1969, 10.1016/j.bbamcr.2014.05.006 Ruvolo, 2015, The interplay between PP2A and microRNAs in leukemia, Front. Oncol., 5, 43, 10.3389/fonc.2015.00043 Sablina, 2007, The tumor suppressor PP2A Abeta regulates the RalA GTPase, Cell, 129, 969, 10.1016/j.cell.2007.03.047 Sablina, 2010, Identification of PP2A complexes and pathways involved in cell transformation, Cancer Res., 70, 10474, 10.1158/0008-5472.CAN-10-2855 Sacco, 2009, Tumor suppressor density-enhanced phosphatase-1 (DEP-1) inhibits the RAS pathway by direct dephosphorylation of ERK1/2 kinases, J. Biol. Chem., 284, 22048, 10.1074/jbc.M109.002758 Sacristan, 2011, Human Cdc14A becomes a cell cycle gene in controlling Cdk1 activity at the G(2)/M transition, Cell Cycle, 10, 387, 10.4161/cc.10.3.14643 Saidak, 2017, Mathematical modelling unveils the essential role of cellular phosphatases in the inhibition of RAF-MEK-ERK signalling by sorafenib in hepatocellular carcinoma cells, Cancer Lett., 392, 1, 10.1016/j.canlet.2017.01.038 Sallman, 2014, PP2A, The achilles heal in MDS with 5q deletion, Front. Oncol., 4, 264, 10.3389/fonc.2014.00264 Samols, 2014, Intralymphatic cutaneous anaplastic large cell lymphoma/lymphomatoid papulosis: expanding the spectrum of CD30-positive lymphoproliferative disorders, Am. J. Surg. Pathol., 38, 1203, 10.1097/PAS.0000000000000217 Sangodkar, 2016, All roads lead to PP2A: exploiting the therapeutic potential of this phosphatase, FEBS J., 283, 1004, 10.1111/febs.13573 Sangodkar, 2017, Activation of tumor suppressor protein PP2A inhibits KRAS-driven tumor growth, J. Clin. Invest., 127, 2081, 10.1172/JCI89548 Sangwan, 2008, Regulation of the Met receptor-tyrosine kinase by the protein-tyrosine phosphatase 1B and T-cell phosphatase, J. Biol. Chem., 283, 34374, 10.1074/jbc.M805916200 Sap, 1994, Receptor tyrosine phosphatase R-PTP-kappa mediates homophilic binding, Mol. Cell. Biol., 14, 1, 10.1128/MCB.14.1.1 Sarhan, 2016, LAR protein tyrosine phosphatase regulates focal adhesions through CDK1, J. Cell Sci., 129, 2962, 10.1242/jcs.191379 Sato, 2010, Multi-step aberrant CpG island hyper-methylation is associated with the progression of adult T-cell leukemia/lymphoma, Am. J. Pathol., 176, 402, 10.2353/ajpath.2010.090236 Schmid, 2015, DUSP4 deficiency caused by promoter hypermethylation drives JNK signaling and tumor cell survival in diffuse large B cell lymphoma, J. Exp. Med., 212, 775, 10.1084/jem.20141957 Schmitz, 2010, Live-cell imaging RNAi screen identifies PP2A-B55alpha and importin-beta1 as key mitotic exit regulators in human cells, Nat. Cell Biol., 12, 886, 10.1038/ncb2092 Schramm, 2015, Mutational dynamics between primary and relapse neuroblastomas, Nat. Genet., 47, 872, 10.1038/ng.3349 Schubbert, 2007, Hyperactive Ras in developmental disorders and cancer, Nat. Rev. Cancer, 7, 295, 10.1038/nrc2109 Schumacher, 2002, Structural basis for the recognition of a bisphosphorylated MAP kinase peptide by human VHR protein Phosphatase, Biochemistry, 41, 3009, 10.1021/bi015799l Schumacher, 2017, Somatic copy number alterations in gastric adenocarcinomas among Asian and Western patients, PLoS One, 12, e0176045, 10.1371/journal.pone.0176045 Schwertassek, 2010, Myristoylation of the dual-specificity phosphatase c-JUN N-terminal kinase (JNK) stimulatory phosphatase 1 is necessary for its activation of JNK signaling and apoptosis, FEBS J., 277, 2463, 10.1111/j.1742-4658.2010.07661.x Sciallis, 2012, Mucosal CD30-positive T-cell lymphoproliferations of the head and neck show a clinicopathologic spectrum similar to cutaneous CD30-positive T-cell lymphoproliferative disorders, Mod. Pathol., 25, 983, 10.1038/modpathol.2012.38 Scrima, 2012, The nonreceptor-type tyrosine phosphatase PTPN13 is a tumor suppressor gene in non-small cell lung cancer, Am. J. Pathol., 180, 1202, 10.1016/j.ajpath.2011.11.038 Sekine, 2006, Regulation of STAT3-mediated signaling by LMW-DSP2, Oncogene, 25, 5801, 10.1038/sj.onc.1209578 Sekine, 2007, DUSP22/LMW-DSP2 regulates estrogen receptor-alpha-mediated signaling through dephosphorylation of Ser-118, Oncogene, 26, 6038, 10.1038/sj.onc.1210426 Sents, 2017, PP2A inactivation mediated by PPP2R4 haploinsufficiency promotes cancer development, Cancer Res., 10.1158/0008-5472.CAN-16-2911 Shan, 2014, Tyr-94 phosphorylation inhibits pyruvate dehydrogenase phosphatase 1 and promotes tumor growth, J. Biol. Chem., 289, 21413, 10.1074/jbc.M114.581124 Shang, 2010, Dual-specificity phosphatase 26 is a novel p53 phosphatase and inhibits p53 tumor suppressor functions in human neuroblastoma, Oncogene, 29, 4938, 10.1038/onc.2010.244 Shen, 2001, Activation of the Jnk signaling pathway by a dual-specificity phosphatase, JSP-1, Proc. Natl. Acad. Sci. U. S. A., 98, 13613, 10.1073/pnas.231499098 Shen, 2014, Upregulation of miR-136 in human non-small cell lung cancer cells promotes Erk1/2 activation by targeting PPP2R2A, Tumour Biol., 35, 631, 10.1007/s13277-013-1087-2 Shen, 2014, Specific control of BMP signaling and mesenchymal differentiation by cytoplasmic phosphatase PPM1H, Cell Res., 24, 727, 10.1038/cr.2014.48 Shen, 2017, DUSP1 inhibits cell proliferation, metastasis and invasion and angiogenesis in gallbladder cancer, Oncotarget, 8, 12133, 10.18632/oncotarget.14815 Shi, 2009, Serine/threonine phosphatases: mechanism through structure, Cell, 139, 468, 10.1016/j.cell.2009.10.006 Shields, 2013, TCPTP regulates SFK and STAT3 signaling and is lost in triple-negative breast cancers, Mol. Cell. Biol., 33, 557, 10.1128/MCB.01016-12 Shih, 2011, Mutation of PPP2R1A: a new clue in unveiling the pathogenesis of uterine serous carcinoma, J. Pathol., 224, 1, 10.1002/path.2884 Shih, 2011, Somatic mutations of PPP2R1A in ovarian and uterine carcinomas, Am. J. Pathol., 178, 1442, 10.1016/j.ajpath.2011.01.009 Shimozato, 2015, Receptor-type protein tyrosine phosphatase kappa directly dephosphorylates CD133 and regulates downstream AKT activation, Oncogene, 34, 1949, 10.1038/onc.2014.141 Shojaee, 2015, Erk negative feedback control enables pre-B cell transformation and represents a therapeutic target in acute lymphoblastic leukemia, Cancer Cell, 28, 114, 10.1016/j.ccell.2015.05.008 Shouse, 2010, A B56gamma mutation in lung cancer disrupts the p53-dependent tumor-suppressor function of protein phosphatase 2A, Oncogene, 29, 3933, 10.1038/onc.2010.161 Shouse, 2016, Novel B55α-PP2A mutations in AML promote AKT T308 phosphorylation and sensitivity to AKT inhibitor-induced growth arrest, Oncotarget, 7, 61081, 10.18632/oncotarget.11209 Shuai, 2003, Regulation of JAK-STAT signalling in the immune system, Nat. Rev. Immunol., 3, 900, 10.1038/nri1226 Sieben, 2005, Differential gene expression in ovarian tumors reveals Dusp 4 and Serpina 5 as key regulators for benign behavior of serous borderline tumors, J. Clin. Oncol., 23, 7257, 10.1200/JCO.2005.02.2541 Sim, 2015, Immunohistochemical expression of dual-specificity protein phosphatase 4 in patients with colorectal adenocarcinoma, Gastroenterol. Res. Pract., 2015, 283764, 10.1155/2015/283764 Simoncic, 2002, The T cell protein tyrosine phosphatase is a negative regulator of janus family kinases 1 and 3, Curr. Biol., 12, 446, 10.1016/S0960-9822(02)00697-8 Singchat, 2016, Genomic alteration in head and neck squamous cell carcinoma (HNSCC) cell lines inferred from karyotyping, molecular cytogenetics, and array comparative genomic hybridization, PLoS One, 11, e0160901, 10.1371/journal.pone.0160901 Singh, 2008, Genome-wide expression profiling reveals transcriptomic variation and perturbed gene networks in androgen-dependent and androgen-independent prostate cancer cells, Cancer Lett., 259, 28, 10.1016/j.canlet.2007.09.018 Sjöblom, 2006, The consensus coding sequences of human breast and colorectal cancers, Science, 314, 268, 10.1126/science.1133427 Smith, 2016, PHLPP negatively regulates cell motility through inhibition of Akt activity and integrin expression in pancreatic cancer cells, Oncotarget, 7, 7801, 10.18632/oncotarget.6848 Smith, 2016, Activation of protein phosphatase 2A in FLT3+ acute myeloid leukemia cells enhances the cytotoxicity of FLT3 tyrosine kinase inhibitors, Oncotarget, 7, 47465, 10.18632/oncotarget.10167 Sobral, 2014, Stable SET knockdown in head and neck squamous cell carcinoma promotes cell invasion and the mesenchymal-like phenotype in vitro, as well as necrosis, cisplatin sensitivity and lymph node metastasis in xenograft tumor models, Mol. Cancer, 13, 32, 10.1186/1476-4598-13-32 Solomon, 2008, Mutational inactivation of PTPRD in glioblastoma multiforme and malignant melanoma, Cancer Res., 68, 10300, 10.1158/0008-5472.CAN-08-3272 Song, 2012, The functions and regulation of the PTEN tumour suppressor, Nat. Rev. Mol. Cell Biol., 13, 283, 10.1038/nrm3330 Song, 2015, Silencing of DUSP6 gene by RNAi-mediation inhibits proliferation and growth in MDA-MB-231 breast cancer cells: an in vitro study, Int. J. Clin. Exp. Med., 8, 10481 Song, 2016, Protein tyrosine phosphatases receptor type D is a potential tumour suppressor gene inactivated by deoxyribonucleic acid methylation in paediatric acute myeloid leukaemia, Acta Paediatr., 105, e132, 10.1111/apa.13284 Sooman, 2014, PTPN6 expression is epigenetically regulated and influences survival and response to chemotherapy in high-grade gliomas, Tumour Biol., 35, 4479, 10.1007/s13277-013-1590-5 Spina, 2016, The genetics of nodal marginal zone lymphoma, Blood, 128, 1362, 10.1182/blood-2016-02-696757 Spring, 2015, The protein tyrosine phosphatase DEP-1/PTPRJ promotes breast cancer cell invasion and metastasis, Oncogene, 34, 5536, 10.1038/onc.2015.9 Stevenson, 2014, DNA methylation of membrane-bound tyrosine phosphatase genes in acute lymphoblastic leukaemia, Leukemia, 28, 787, 10.1038/leu.2013.270 Stokoe, 2001, PTEN, Curr. Biol., 11, R502, 10.1016/S0960-9822(01)00303-7 Su, 2013, Epigenetic silencing of PTPRR activates MAPK signaling, promotes metastasis and serves as a biomarker of invasive cervical cancer, Oncogene, 32, 15, 10.1038/onc.2012.29 Su, 2013, PTPN12 inhibits oral squamous epithelial carcinoma cell proliferation and invasion and can be used as a prognostic marker, Med. Oncol., 30, 618, 10.1007/s12032-013-0618-4 Su, 2016, Disrupting VEGF-A paracrine and autocrine loops by targeting SHP-1 suppresses triple negative breast cancer metastasis, Sci. Rep., 6, 28888, 10.1038/srep28888 Suarez Pestana, 1999, The transmembrane protein tyrosine phosphatase RPTPsigma modulates signaling of the epidermal growth factor receptor in A431 cells, Oncogene, 18, 4069, 10.1038/sj.onc.1202794 Sudhir, 2015, Loss of PTPRM associates with the pathogenic development of colorectal adenoma-carcinoma sequence, Sci. Rep., 5, 9633, 10.1038/srep09633 Suganuma, 1988, Okadaic acid: an additional non-phorbol-12-tetradecanoate-13-acetate-type tumor promoter, Proc. Natl. Acad. Sci. U. S. A., 85, 1768, 10.1073/pnas.85.6.1768 Sugiura, 2008, Protein phosphatase 1H, overexpressed in colon adenocarcinoma, is associated with CSE1L, Cancer Biol. Ther., 7, 285, 10.4161/cbt.7.2.5302 Sun, 2008, Quantitative proteomic signature of liver cancer cells: tissue transglutaminase 2 could be a novel protein candidate of human hepatocellular carcinoma, J. Proteome Res., 7, 3847, 10.1021/pr800153s Sun, 2009, PPM1A and PPM1B act as IKKbeta phosphatases to terminate TNFalpha-induced IKKbeta-NF-kappaB activation, Cell. Signal., 21, 95, 10.1016/j.cellsig.2008.09.012 Sun, 2011, Activation of multiple proto-oncogenic tyrosine kinases in breast cancer via loss of the PTPN12 phosphatase, Cell, 144, 703, 10.1016/j.cell.2011.02.003 Sun, 2012, Protein tyrosine phosphatase μ (PTP μ or PTPRM), a negative regulator of proliferation and invasion of breast cancer cells, is associated with disease prognosis, PLoS One, 7, e50183, 10.1371/journal.pone.0050183 Sun, 2013, Protein tyrosine phosphatase kappa (PTPRK) is a negative regulator of adhesion and invasion of breast cancer cells, and associates with poor prognosis of breast cancer, J. Cancer Res. Clin. Oncol., 139, 1129, 10.1007/s00432-013-1421-5 Sun, 2013, Receptor-like protein tyrosine phosphatase κ negatively regulates the apoptosis of prostate cancer cells via the JNK pathway, Int. J. Oncol., 43, 1560, 10.3892/ijo.2013.2082 Sun, 2017, Dual roles of protein tyrosine phosphatase kappa in coordinating angiogenesis induced by pro-angiogenic factors, Int. J. Oncol., 50, 1127, 10.3892/ijo.2017.3884 Szaumkessel, 2017, Recurrent epigenetic silencing of the PTPRD tumor suppressor in laryngeal squamous cell carcinoma, Tumour Biol., 39, 10.1177/1010428317691427 Tai, 2010, The investigation of mitogen-activated protein kinase phosphatase-1 as a potential pharmacological target in non-small cell lung carcinomas, assisted by non-invasive molecular imaging, BMC Cancer, 10, 95, 10.1186/1471-2407-10-95 Tai, 2014, Discovery of novel Src homology region 2 domain-containing phosphatase 1 agonists from sorafenib for the treatment of hepatocellular carcinoma, Hepatology, 59, 190, 10.1002/hep.26640 Takagi, 2000, Alterations of the PPP2R1B gene located at 11q23 in human colorectal cancers, Gut, 47, 268, 10.1136/gut.47.2.268 Takahashi, 2006, A monoclonal antibody against CD148, a receptor-like tyrosine phosphatase, inhibits endothelial-cell growth and angiogenesis, Blood, 108, 1234, 10.1182/blood-2005-10-4296 Takahashi, 2012, DNA damage signaling triggers degradation of histone methyltransferases through APC/C(Cdh1) in senescent cells, Mol. Cell, 45, 123, 10.1016/j.molcel.2011.10.018 Tamaki, 2004, PPP2R1B gene alterations inhibit interaction of PP2A-Abeta and PP2A-C proteins in colorectal cancers, Oncol. Rep., 11, 655 Tan, 2010, B55β-associated PP2A complex controls PDK1-directed myc signaling and modulates rapamycin sensitivity in colorectal cancer, Cancer Cell, 18, 459, 10.1016/j.ccr.2010.10.021 Tanuma, 2009, Protein phosphatase Dusp26 associates with KIF3 motor and promotes N-cadherin-mediated cell-cell adhesion, Oncogene, 28, 752, 10.1038/onc.2008.431 Tarcic, 2009, An unbiased screen identifies DEP-1 tumor suppressor as a phosphatase controlling EGFR endocytosis, Curr. Biol., 19, 1788, 10.1016/j.cub.2009.09.048 ten Hoeve, 2002, Identification of a nuclear Stat1 protein tyrosine phosphatase, Mol. Cell. Biol., 22, 5662, 10.1128/MCB.22.16.5662-5668.2002 Teng, 2016, Role of PHLPP1 in inflammation response: its loss contributes to gliomas development and progression, Int. Immunopharmacol., 34, 229, 10.1016/j.intimp.2016.02.034 Tiganis, 1998, Epidermal growth factor receptor and the adaptor protein p52Shc are specific substrates of T-cell protein tyrosine phosphatase, Mol. Cell. Biol., 18, 1622, 10.1128/MCB.18.3.1622 Toda-Ishii, 2016, Clinicopathological effects of protein phosphatase 2, regulatory subunit A, alpha mutations in gastrointestinal stromal tumors, Mod. Pathol., 29, 1424, 10.1038/modpathol.2016.138 Todd, 1999, Extracellular regulated kinases (ERK) 1 and ERK2 are authentic substrates for the dual-specificity protein-tyrosine phosphatase VHR. A novel role in down-regulating the ERK pathway, J. Biol. Chem., 274, 13271, 10.1074/jbc.274.19.13271 Todd, 2002, Dual-specificity protein tyrosine phosphatase VHR down-regulates c-Jun N-terminal kinase (JNK), Oncogene, 21, 2573, 10.1038/sj.onc.1205344 Tonks, 2013, Protein tyrosine phosphatases–from housekeeping enzymes to master regulators of signal transduction, FEBS J., 280, 346, 10.1111/febs.12077 Torres, 2017, Loss of DUSP3 activity radiosensitizes human tumor cell lines via attenuation of DNA repair pathways, Biochim. Biophys. Acta, 1861, 1879, 10.1016/j.bbagen.2017.04.004 Trapasso, 2000, Rat protein tyrosine phosphatase eta suppresses the neoplastic phenotype of retrovirally transformed thyroid cells through the stabilization of p27(Kip1), Mol. Cell. Biol., 20, 9236, 10.1128/MCB.20.24.9236-9246.2000 Trapasso, 2004, Restoration of receptor-type protein tyrosine phosphatase eta function inhibits human pancreatic carcinoma cell growth in vitro and in vivo, Carcinogenesis, 25, 2107, 10.1093/carcin/bgh224 Trojan, 2005, Identification of metastasis-associated genes in prostate cancer by genetic profiling of human prostate cancer cell lines, Anticancer Res., 25, 183 Tsuboi, 2008, The tyrosine phosphatase CD148 interacts with the p85 regulatory subunit of phosphoinositide 3-kinase, Biochem. J., 413, 193, 10.1042/BJ20071317 Tumurbaatar, 2011, Human Cdc14B promotes progression through mitosis by dephosphorylating Cdc25 and regulating Cdk1/cyclin B activity, PLoS One, 6, e14711, 10.1371/journal.pone.0014711 Ueda, 2003, Dual-specificity phosphatase 5 (DUSP5) as a direct transcriptional target of tumor suppressor p53, Oncogene, 22, 5586, 10.1038/sj.onc.1206845 Uhm, 2009, Differential methylation pattern of ID4, SFRP1, and SHP1 between acute myeloid leukemia and chronic myeloid leukemia, J. Korean Med. Sci., 24, 493, 10.3346/jkms.2009.24.3.493 Van Renne, 2017, miR -135a-5p-mediated downregulation of protein tyrosine phosphatase receptor delta is a candidate driver of HCV-associated hepatocarcinogenesis, Gut Vasudevan, 2005, MKP-8, a novel MAPK phosphatase that inhibits p38 kinase, Biochem. Biophys. Res. Commun., 330, 511, 10.1016/j.bbrc.2005.03.028 Vazquez-Novelle, 2010, Human Cdc14A phosphatase modulates the G2/M transition through Cdc25A and Cdc25B, J. Biol. Chem., 285, 40544, 10.1074/jbc.M110.133009 Veeramani, 2005, Cellular prostatic acid phosphatase: a protein tyrosine phosphatase involved in androgen-independent proliferation of prostate cancer, Endocr. Relat. Cancer, 12, 805, 10.1677/erc.1.00950 Veeramani, 2009, Revisiting histidine-dependent acid phosphatases: a distinct group of tyrosine phosphatases, Trends Biochem. Sci., 34, 273, 10.1016/j.tibs.2009.03.002 Veeriah, 2009, The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancers, Proc. Natl. Acad. Sci. U. S. A., 106, 9435, 10.1073/pnas.0900571106 Venkatachalam, 2010, Germline epigenetic silencing of the tumor suppressor gene PTPRJ in early-onset familial colorectal cancer, Gastroenterology, 139, 2221, 10.1053/j.gastro.2010.08.063 Venter, 2005, Complex CGH alterations on chromosome arm 8p at candidate tumor suppressor gene loci in breast cancer cell lines, Cancer Genet. Cytogenet., 160, 134, 10.1016/j.cancergencyto.2004.12.007 Vermeer, 2012, ErbB2, EphrinB1, Src kinase and PTPN13 signaling complex regulates MAP kinase signaling in human cancers, PLoS One, 7, e30447, 10.1371/journal.pone.0030447 Vezzalini, 2007, Expression of transmembrane protein tyrosine phosphatase gamma (PTPgamma) in normal and neoplastic human tissues, Histopathology, 50, 615, 10.1111/j.1365-2559.2007.02661.x Vicent, 2004, Mitogen-activated protein kinase phosphatase-1 is overexpressed in non-small cell lung cancer and is an independent predictor of outcome in patients, Clin. Cancer Res., 10, 3639, 10.1158/1078-0432.CCR-03-0771 Voss, 2011, Ppm1E is an in cellulo AMP-activated protein kinase phosphatase, Cell. Signal., 23, 114, 10.1016/j.cellsig.2010.08.010 Wadham, 2003, The protein tyrosine phosphatase Pez is a major phosphatase of adherens junctions and dephosphorylates beta-catenin, Mol. Biol. Cell, 14, 2520, 10.1091/mbc.e02-09-0577 Wagner, 2009, Signal integration by JNK and p38 MAPK pathways in cancer development, Nat. Rev. Cancer, 9, 537, 10.1038/nrc2694 Wagner, 2013, KDM2A promotes lung tumorigenesis by epigenetically enhancing ERK1/2 signaling, J. Clin. Invest., 123, 5231, 10.1172/JCI68642 Waha, 2010, Epigenetic downregulation of mitogen-activated protein kinase phosphatase MKP-2 relieves its growth suppressive activity in glioma cells, Cancer Res., 70, 1689, 10.1158/0008-5472.CAN-09-3218 Walia, 2014, Mutational and functional analysis of the tumor-suppressor PTPRD in human melanoma, Hum. Mutat., 35, 1301 Walter, 1990, Association of protein phosphatase 2A with polyoma virus medium tumor antigen, Proc. Natl. Acad. Sci. U. S. A., 87, 2521, 10.1073/pnas.87.7.2521 Wang, 1998, Alterations of the PPP2R1B gene in human lung and colon cancer, Science, 282, 284, 10.1126/science.282.5387.284 Wang, 2003, Overexpression of mitogen-activated protein kinase phosphatases MKP1, MKP2 in human breast cancer, Cancer Lett., 191, 229, 10.1016/S0304-3835(02)00612-2 Wang, 2004, Mutational analysis of the tyrosine phosphatome in colorectal cancers, Science, 304, 1164, 10.1126/science.1096096 Wang, 2006, Biochemical and biological characterization of a neuroendocrine-associated phosphatase, J. Neurochem., 98, 89, 10.1111/j.1471-4159.2006.03852.x Wang, 2007, The tumor suppressor DAPK is reciprocally regulated by tyrosine kinase Src and phosphatase LAR, Mol. Cell, 27, 701, 10.1016/j.molcel.2007.06.037 Wang, 2008, NEAP causes down-regulation of EGFR, subsequently induces the suppression of NGF-induced differentiation in PC12 cells, J. Neurochem., 107, 1544, 10.1111/j.1471-4159.2008.05714.x Wang, 2010, Activation of protein serine/threonine phosphatase PP2Cα efficiently prevents liver fibrosis, PLoS One, 5, e14230, 10.1371/journal.pone.0014230 Wang, 2011, Vaccinia H1-related phosphatase is a phosphatase of ErbB receptors and is down-regulated in non-small cell lung cancer, J. Biol. Chem., 286, 10177, 10.1074/jbc.M110.163295 Wang, 2012, PTPN14 is required for the density-dependent control of YAP1, Genes Dev., 26, 1959, 10.1101/gad.192955.112 Wang, 2014, Reduced expression of PTPRD correlates with poor prognosis in gastric adenocarcinoma, PLoS One, 9, e113754, 10.1371/journal.pone.0113754 Wang, 2014, High-resolution genomic copy number profiling of primary intraocular lymphoma by single nucleotide polymorphism microarrays, Cancer Sci., 105, 592, 10.1111/cas.12388 Wang, 2014, CIP2A mediates erlotinib-induced apoptosis in non-small cell lung cancer cells without EGFR mutation, Lung Cancer, 85, 152, 10.1016/j.lungcan.2014.05.024 Wang, 2015, Protein tyrosine phosphatase receptor S acts as a metastatic suppressor in hepatocellular carcinoma by control of epithermal growth factor receptor-induced epithelial-mesenchymal transition, Hepatology, 62, 1201, 10.1002/hep.27911 Wang, 2015, MiR-21 promotes intrahepatic cholangiocarcinoma proliferation and growth in vitro and in vivo by targeting PTPN14 and PTEN, Oncotarget, 6, 5932, 10.18632/oncotarget.3465 Wang, 2015, Expression and clinical significance of PTPN14 in cholangiocarcinoma, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi., 31, 1251 Wang, 2015, Cofilin-phosphatase slingshot-1L (SSH1L) is over-expressed in pancreatic cancer (PC) and contributes to tumor cell migration, Cancer Lett., 360, 171, 10.1016/j.canlet.2015.02.015 Wang, 2016, DCAF4L2 promotes colorectal cancer invasion and metastasis via mediating degradation of NFκb negative regulator PPM1B, Am. J. Transl. Res., 8, 405 Wang, 2016, Role for DUSP1 (dual-specificity protein phosphatase 1) in the regulation of autophagy, Autophagy, 10, 1791, 10.1080/15548627.2016.1203483 Warabi, 2000, Expression of protein tyrosine phosphatases and its significance in esophageal cancer, Exp. Mol. Pathol., 68, 187, 10.1006/exmp.2000.2303 Warfel, 2011, Mislocalization of the E3 ligase, β-transducin repeat-containing protein 1 (β-TrCP1), in glioblastoma uncouples negative feedback between the pleckstrin homology domain leucine-rich repeat protein phosphatase 1 (PHLPP1) and Akt, J. Biol. Chem., 286, 19777, 10.1074/jbc.M111.237081 Warmka, 2004, Mitogen-activated protein kinase phosphatase-3 is a tumor promoter target in initiated cells that express oncogenic Ras, J. Biol. Chem., 279, 33085, 10.1074/jbc.M403120200 Watt, 2017, Functional importance of PP2A regulatory subunit loss in breast cancer, Breast Cancer Res. Treat., 10.1007/s10549-017-4403-5 Weir, 2007, Characterizing the cancer genome in lung adenocarcinoma, Nature, 450, 893, 10.1038/nature06358 Wen, 2013, Downregulation of PHLPP expression contributes to hypoxia-induced resistance to chemotherapy in colon cancer cells, Mol. Cell. Biol., 33, 4594, 10.1128/MCB.00695-13 Wittig-Blaich, 2017, Systematic screening of isogenic cancer cells identifies DUSP6 as context-specific synthetic lethal target in melanoma, Oncotarget, 8, 23760, 10.18632/oncotarget.15863 Wlodarchak, 2016, PP2A as a master regulator of the cell cycle, Crit. Rev. Biochem. Mol. Biol., 51, 162, 10.3109/10409238.2016.1143913 Wong, 2015, Regulation of autophagy by coordinated action of mTORC1 and protein phosphatase 2A, Nat. Commun., 6, 8048, 10.1038/ncomms9048 Woodward, 2017, Genomic complexity and targeted genes in anaplastic thyroid cancer cell lines, Endocr. Relat. Cancer, 24, 209, 10.1530/ERC-16-0522 Wu, 2003, The function of the protein tyrosine phosphatase SHP-1 in cancer, Gene, 306, 1, 10.1016/S0378-1119(03)00400-1 Wu, 2006, PTPN3 and PTPN4 tyrosine phosphatase expression in human gastric adenocarcinoma, Anticancer Res., 26, 1643 Wu, 2010, Identification of tyrosine-phosphorylated proteins associated with lung cancer metastasis using label-free quantitative analyses, J. Proteome Res., 9, 4102, 10.1021/pr1006153 Wu, 2011, Decreased expression of dual-specificity phosphatase 9 is associated with poor prognosis in clear cell renal cell carcinoma, BMC Cancer, 11, 413, 10.1186/1471-2407-11-413 Wu, 2013, Low expression of tyrosine-protein phosphatase nonreceptor type 12 is associated with lymph node metastasis and poor prognosis in operable triple-negative breast cancer, Asian Pac. J. Cancer Prev., 14, 287, 10.7314/APJCP.2013.14.1.287 Wu, 2015, Epigenetic silencing of DUSP9 induces the proliferation of human gastric cancer by activating JNK signaling, Oncol. Rep., 34, 121, 10.3892/or.2015.3998 Xing, 2015, Anaplastic large cell lymphomas: ALK positive, ALK negative, and primary cutaneous, Adv. Anat. Pathol., 22, 29, 10.1097/PAP.0000000000000047 Xiong, 2017, PHLPP regulates hexokinase 2-dependent glucose metabolism in colon cancer cells, Cell Death Discov., 3, 16103, 10.1038/cddiscovery.2016.103 Xu, 2005, Receptor-type protein-tyrosine phosphatase-kappa regulates epidermal growth factor receptor function, J. Biol. Chem., 280, 42694, 10.1074/jbc.M507722200 Xu, 2005, Abrogation of DUSP6 by hypermethylation in human pancreatic cancer, J. Hum. Genet., 50, 159, 10.1007/s10038-005-0235-y Xu, 2014, Interaction of PTPRO and TLR4 signaling in hepatocellular carcinoma, Tumour Biol., 35, 10267, 10.1007/s13277-014-2302-5 Xu, 2016, miR-26a desensitizes non-small cell lung cancer cells to tyrosine kinase inhibitors by targeting PTPN13, Oncotarget, 7, 45687, 10.18632/oncotarget.9920 Xu, 2017, Genomic characteristics of pancreatic squamous cell carcinoma, an investigation by using high throughput sequencing after in-solution hybrid capture, Oncotarget, 8, 14620, 10.18632/oncotarget.14678 Xunyi, 2012, Clinicopathological significance of PTPN12 expression in human breast cancer, Braz. J. Med. Biol. Res., 45, 1334, 10.1590/S0100-879X2012007500163 Yan, 2002, Physical and functional interaction between receptor-like protein tyrosine phosphatase PCP-2 and beta-catenin, Biochemistry, 41, 15854, 10.1021/bi026095u Yan, 2006, Protein-tyrosine phosphatase PCP-2 inhibits beta-catenin signaling and increases E-cadherin-dependent cell adhesion, J. Biol. Chem., 281, 15423, 10.1074/jbc.M602607200 Yan, 2010, PP2A T61 epsilon is an inhibitor of MAP4K3 in nutrient signaling to mTOR, Mol. Cell, 37, 633, 10.1016/j.molcel.2010.01.031 Yan, 2015, Blockage of PTPRJ promotes cell growth and resistance to 5-FU through activation of JAK1/STAT3 in the cervical carcinoma cell line C33A, Oncol. Rep., 33, 1737, 10.3892/or.2015.3769 Yan, 2016, Dual specificity phosphatase 5 is a novel prognostic indicator for patients with advanced colorectal cancer, Am. J. Cancer Res., 6, 2323 Yang, 2015, Methylated alteration of SHP1 complements mutation of JAK2 tyrosine kinase in patients with myeloproliferative neoplasm, Asian Pac. J. Cancer Prev., 16, 2219, 10.7314/APJCP.2015.16.6.2219 Yang, 2016, Wang B: miR-186 downregulates protein phosphatase PPM1B in bladder cancer and mediates G1-S phase transition, Tumour Biol., 37, 4331, 10.1007/s13277-015-4117-4 Yeh, 2006, Genetic characterization of fas-associated phosphatase-1 as a putative tumor suppressor gene on chromosome 4q21.3 in hepatocellular carcinoma, Clin. Cancer Res., 12, 1097, 10.1158/1078-0432.CCR-05-1383 Yin, 2003, PAC1 phosphatase is a transcription target of p53 in signalling apoptosis and growth suppression, Nature, 422, 527, 10.1038/nature01519 Yip-Schneider, 2001, Pancreatic tumor cells with mutant K-ras suppress ERK activity by MEK-dependent induction of MAP kinase phosphatase-2, Biochem. Biophys. Res. Commun., 280, 992, 10.1006/bbrc.2001.4243 Yokoyama, 1997, The characteristic gene expressions of MAPK phosphatases 1 and 2 in hepatocarcinogenesis, rat ascites hepatoma cells, and regenerating rat liver, Biochem. Biophys. Res. Commun., 239, 746, 10.1006/bbrc.1997.7547 Young, 2009, TC-PTP is required for the maintenance of MYC-driven B-cell lymphomas, Blood, 114, 5016, 10.1182/blood-2008-12-196709 Yu, 2007, Aberrant splicing of cyclin-dependent kinase-associated protein phosphatase KAP increases proliferation and migration in glioblastoma, Cancer Res., 67, 130, 10.1158/0008-5472.CAN-06-2478 Yu, 2007, A novel amplification target, DUSP26, promotes anaplastic thyroid cancer cell growth by inhibiting p38 MAPK activity, Oncogene, 26, 1178, 10.1038/sj.onc.1209899 Yu, 2012, Expression profiling during mammary epithelial cell three-dimensional morphogenesis identifies PTPRO as a novel regulator of morphogenesis and ErbB2-mediated transformation, Mol. Cell. Biol., 32, 3913, 10.1128/MCB.00068-12 Yu, 2013, Inhibition of CIP2A determines erlotinib-induced apoptosis in hepatocellular carcinoma, Biochem. Pharmacol., 85, 356, 10.1016/j.bcp.2012.11.009 Yu, 2015, Decreased expression of dual specificity phosphatase 22 in colorectal cancer and its potential prognostic relevance for stage IV CRC patients, Tumour Biol., 36, 8531, 10.1007/s13277-015-3588-7 Yuan, 2010, Protein-tyrosine phosphatase PTPN9 negatively regulates ErbB2 and epidermal growth factor receptor signaling in breast cancer cells, J. Biol. Chem., 285, 14861, 10.1074/jbc.M109.099879 Yuwanita, 2015, Increased metastasis with loss of E2F2 in Myc-driven tumors, Oncotarget, 6, 38210, 10.18632/oncotarget.5690 Zaidi, 2009, Altered Runx1 subnuclear targeting enhances myeloid cell proliferation and blocks differentiation by activating a miR-24/MKP-7/MAPK network, Cancer Res., 69, 8249, 10.1158/0008-5472.CAN-09-1567 Zang, 2015, Identifying CDKN3 gene expression as a prognostic biomarker in lung adenocarcinoma via meta-analysis, Cancer Inform., 14, 183 Zanke, 1992, Cloning and expression of an inducible lymphoid-specific, protein tyrosine phosphatase (HePTPase), Eur. J. Immunol., 22, 235, 10.1002/eji.1830220134 Zanke, 1994, A hematopoietic protein tyrosine phosphatase (HePTP) gene that is amplified and overexpressed in myeloid malignancies maps to chromosome 1q32.1, Leukemia, 8, 236 Zhan, 2016, Tumour-suppressive role of PTPN13 in hepatocellular carcinoma and its clinical significance, Tumour Biol., 37, 9691, 10.1007/s13277-016-4843-2 Zhang, 2005, STAT3- and DNA methyltransferase 1-mediated epigenetic silencing of SHP-1 tyrosine phosphatase tumor suppressor gene in malignant T lymphocytes, Proc. Natl. Acad. Sci. U. S. A., 102, 6948, 10.1073/pnas.0501959102 Zhang, 2007, Identification of STAT3 as a substrate of receptor protein tyrosine phosphatase T, Proc. Natl. Acad. Sci. U. S. A., 104, 4060, 10.1073/pnas.0611665104 Zhang, 2009, PR55 alpha, a regulatory subunit of PP2A, specifically regulates PP2A-mediated beta-catenin dephosphorylation, J. Biol. Chem., 284, 22649, 10.1074/jbc.M109.013698 Zhang, 2009, Cancer-derived mutations in the fibronectin III repeats of PTPRT/PTPrho inhibit cell-cell aggregation, Cell Commun. Adhes., 16, 146 Zhang, 2013, Identification and functional characterization of p130Cas as a substrate of protein tyrosine phosphatase nonreceptor 14, Oncogene, 32, 2087, 10.1038/onc.2012.220 Zhang, 2014, Incidence and prognostic value of multiple gene promoter methylations in gliomas, J. Neurooncol., 116, 349, 10.1007/s11060-013-1301-5 Zhang, 2014, DUSP1 phosphatase regulates the proinflammatory milieu in head and neck squamous cell carcinoma, Cancer Res., 74, 7191, 10.1158/0008-5472.CAN-14-1379 Zhang, 2015, CDKN3 knockdown reduces cell proliferation, invasion and promotes apoptosis in human ovarian cancer, Int. J. Clin. Exp. Pathol., 8, 4535 Zhang, 2015, DUSP16 ablation arrests the cell cycle and induces cellular senescence, FEBS J., 282, 4580, 10.1111/febs.13518 Zhang, 2016, Genetic variations in the Hippo signaling pathway and breast cancer risk in African American women in the AMBER Consortium, Carcinogenesis, 37, 951, 10.1093/carcin/bgw077 Zhang, 2016, MicroRNA-587 antagonizes 5-FU-induced apoptosis and confers drug resistance by regulating PPP2R1B expression in colorectal cancer, Cell Death Dis., 7, e2525, 10.1038/cddis.2016.450 Zhang, 2017, Tumor suppressor PTPRJ is a target of miR-155 in colorectal cancer, J. Cell. Biochem., 118, 3391, 10.1002/jcb.25995 Zhao, 2017, Synthetic essentiality: targeting tumor suppressor deficiencies in cancer, Bioessays, 39, 10.1002/bies.201700076 Zhao, 2010, Identification and functional characterization of paxillin as a target of protein tyrosine phosphatase receptor T, Proc. Natl. Acad. Sci. U. S. A., 107, 2592, 10.1073/pnas.0914884107 Zhao, 2017, Regulation of paxillin-p130-PI3K-AKT signaling axis by Src and PTPRT impacts colon tumorigenesis, Oncotarget, 8, 48782, 10.18632/oncotarget.10654 Zhao, 2017, Synthetic essentiality of chromatin remodelling factor CHD1 in PTEN-deficient cancer, Nature, 542, 484, 10.1038/nature21357 Zheng, 2013, Regulation of tumor cell migration by protein tyrosine phosphatase (PTP)-proline-, glutamate-, serine-,and threonine-rich sequence (PEST), Chin. J. Cancer, 32, 75, 10.5732/cjc.012.10084 Zheng, 2008, Apoptosis of estrogen-receptor negative breast cancer and colon cancer cell lines by PTP alpha and src RNAi, Int. J. Cancer, 122, 1999, 10.1002/ijc.23321 Zhi, 2011, PTPH1 cooperates with vitamin D receptor to stimulate breast cancer growth through their mutual stabilization, Oncogene, 30, 1706, 10.1038/onc.2010.543 Zhou, 2013, Characterization of nuclear localization signal in the N terminus of integrin-linked kinase-associated phosphatase (ILKAP) and its essential role in the down-regulation of RSK2 protein signaling, J. Biol. Chem., 288, 6259, 10.1074/jbc.M112.432195 Zhou, 2015, Aberrant expression of PHLPP1 and PHLPP2 correlates with poor prognosis in patients with hypopharyngeal squamous cell carcinoma, PLoS One, 10, e0119405, 10.1371/journal.pone.0119405 Zhou, 2015, MiR-34c-3p suppresses the proliferation and invasion of non-small cell lung cancer (NSCLC) by inhibiting PAC1/MAPK pathway, Int. J. Clin. Exp. Pathol., 8, 6312 Zhou, 2017, Hepatitis C virus NS3 protein enhances hepatocellular carcinoma cell invasion by promoting PPM1A ubiquitination and degradation, J. Exp. Clin. Cancer Res., 36, 42, 10.1186/s13046-017-0510-8 Zhu, 2008, Protein tyrosine phosphatase PTPN13 negatively regulates Her2/ErbB2 malignant signaling, Oncogene, 27, 2525, 10.1038/sj.onc.1210922 Zhu, 2016, Effect of PPM1H on malignant phenotype of human pancreatic cancer cells, Oncol. Rep., 36, 2926, 10.3892/or.2016.5065 Zhuang, 2016, Protein phosphatase 2A-B55δ enhances chemotherapy sensitivity of human hepatocellular carcinoma under the regulation of microRNA-133b, J. Exp. Clin. Cancer Res., 35, 67, 10.1186/s13046-016-0341-z Zwaenepoel, 2010, Protein phosphatase 2A PR130/B′′alpha1 subunit binds to the SH2 domain-containing inositol polyphosphate 5-phosphatase 2 and prevents epidermal growth factor (EGF)-induced EGF receptor degradation sustaining EGF-mediated signaling, FASEB J., 24, 538, 10.1096/fj.09-140228